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This thesis describes some experiments performed
using the technique of microelectrophoresis. The object
of the experiments was to examine the suggestion that
potentiation of responses to monoamines by tricyclic anti¬
depressant drugs resulted from the blockade of monoamine
uptake into presynaptic terminals.
1. The sensitivity of single neurones to microelectro-
phoretically applied dopamine, noradrenaline, 5-
hydroxytryptamine and acetylcholine was investigated
in the caudate nucleus of the rat, anaesthetised
with halo thane.
a) Both excitatory and depressant responses to
each of the agonists could be observed. There
was a high correlation between the direction of
responses to dopamine and noradrenaline, whereas
there was no significant correlation, either
positive or negative, between the direction of
responses to dopamine and acetylcholine.
b) The effect of desipramine was studied on
both excitatory and depressant responses to
dopamine, noradrenaline and 5-hydroxytryptamine,
and on excitatory responses to acetylcholine.
Both potentiation and antagonism of neuronal
responses to monoamines and acetylcholine could
be observed after a brief application of
desipramine.
c) Excitatory responses to glutamate were not
affected by desipramine.
d) The observation that responses to dopamine
and noradrenaline can be potentiated by desip¬
ramine in the caudate nucleus cannot be exp¬
lained on the basis of uptake blockade, since
data in the literature show that desipramine
does not block the uptake of catecholamines in
the caudate nucleus.
2. The technique of microelectrophoresis was used in
order to study the effects of iprindole on single
neurones in the cerebral cortex and caudate nucleus
of the rat.
a) Both potentiation and antagonism of neuronal
responses to noradrenaline, dopamine and 5-
hydroxytryptamine could be observed after a
brief application of iprindole. Potentiation
and antagonism often occurred after the same
application of iprindole, antagonism always
preceding potentiation.
b) Responses to acetylcholine were affected by
iprindole similarly: both potentiation and
antagonism of the responses could be observed.
c) Responses to glutamate were not affected
by iprindole.
d) It is concluded that the poxentiation of
responses to monoamines by iprindole cannot be
explained on the basis of uptake blockade, since
data in the literature show that iprindole does
not block the uptake of monoamines into brain
tissue.
The technique of microelectrophoresis was used in
order to study the effects of desipramine on res¬
ponses of single cortical neurones to mescaline.
a) Both potentiation and antagonism of neuronal
responses to mescaline could be observed after
a brief application of desipramine.
b) Responses to glutamate were not affected
by desipramine.
Biochemical techniques were used to study the
uptake of radioactively-labelled noradrenaline
and mescaline into synaptosomes prepared from
rat cerebral cortex.
a) Mescaline is accumulated into synaptosomes
by a temperature and sodium-dependent process.
b) The uptake of mescaline is not affected by
desipramine.
c) The uptake of noradrenaline is inhibited by
mescaline in a non-competitive manner.
d) It is concluded that the uptake of mescaline
is not brought about by the noradrenaline uptake
mechanism.
e) It is concluded that the potentiation of
neuronal responses" to mescaline by desipramine
cannot be explained by the blockade of mescaline
uptake.
5. a) It is suggested that uptake blockade is
not a prerequisite for the potentiation of
neuronal responses to the monoamines by tri¬
cyclic ant idepres saint drugs.
b) It is proposed that potentiation may be
due to the blockade of masked, functionally
opposite, receptors on the postsynaptic cell.
c) It is suggested that the common pharmaco¬
logical action of the tricyclic antidepressant
drugs may be the ability to block both mono¬
amine and acetylcholine receptors in the brain.
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1:1 OBJECT OF STUDY
Tricyclic antidepressant drugs have been shown to
potentiate responses to exogenously applied monoamines in
peripheral and central pharmacological test systems (Gyermek
& Possemato, 1960; Bradshaw, Roberts & Szabadi, 1974).
Furthermore, it has been demonstrated that the tricyclic anti¬
depressant drugs block the uptake of monoamines into pre¬
synaptic terminals (Iversen, 1965; Ross & Renyi, 1969).
A causal relationship between these two effects is assumed
by the uptake blockade hypothesis of potentiation (Iversen,
1974). According to this hypothesis, the blockade of
monoamine uptake results in an increased monoamine con¬
centration ftt receptoTs which, in turn, is reflected in
an enhanced response to the monoamine.
The experiments described in this thesis were conducted
in an attempt to test the uptake blockade hypothesis of
potentiation. The microelectrophoretic technique was used
to determine the effect of tricyclic antidepressant
drugs on responses of single neurones to monoamines in situ¬
ations where uptake blockade was unlikely to contribute to
the effects observed.
Thus, the effect of desipramine on responses of single
caudate neurones to noradrenaline (NA), 5-hydroxytryptamine
(5HT) and dopamine (DA) was examined because desipramine
has been shown not to block the uptake of these amines into
nerve terminals in the caudate nucleus (Ross & Renyi, 1967,
1969). Similarly, iprindole has been shown to have no
effect on the uptake of monoamines into nerve terminals in
- 2 -
both the cerebral cortex and the caudate nucleus (Ross,
Renyi & Ogren, 1971). Therefore, the effect of iprindole
on responses of single neurones in the cerebral cortex and
caudate nucleus to NA, 5HT a&d DA was examined.
Finally, it has been reported that mescaline can
mimic the actions of other monoamines when applied by micro¬
electrophoresis to single cortical neurones (Bevan, Bradshaw,
Roberts & Szabadi, 1974a), and it has been reported that
mescaline has a very low affinity for NA-uptake mechanisms
in peripheral adrenergic nerves (Iversen, 1967). Thus the
effect of desipramine on responses of single cortical
neurones to mescaline was examined. As there have been
no data, however, concerning the uptake of mescaline into
brain tissue, the uptake of mescaline into synaptosomes
prepared from rat brain cerebral cortex was also examined.
- 3 -
1:2 MONOAMINE THEORY OF AFFECTIVE DISORDERS
Contemporary research interest in the monoamines
and the affective disorders was stimulated by the discovery
that iproniazid, a monoamine oxidase inhibitor, was also a
therapeutically effective antidepressant agent (Crane, 1957;
Loomer, Saunders & Kline, 1957). Reserpine was used in
sma11 doses to treat hypertension (Kline, 1959), but often
produced severe depressive reactions (Muller, Pryor,
Gibbons & Orgain, 1955; Harris, 1957).
The common denominator in the action of these
drugs appeared to be an interaction with the metabolism of
the monoamines-noradrenaline (NA)~, Sy-Ibyd-roxytryptamipe .(5HT)
-ril *
and dopamine (DA). Reserpine depleted the brain of these
monoamines (Shore, 1962) whereas iproniazid tended to
elevate monoamine levels (Schildkraut, 1965). The fact
that these drugs could either produce or relieve depres¬
sion whilst altering monoamine levels in opposite ways
suggested that perhaps both mania and depression may be
caused by alterations in monoamine metabolism (Jacobsen,
1964).
The monoamine theory of affective disorders pro¬
poses that impaired function of monoamine containing
neuronal systems forms the basis of the affective dis¬
orders: decreased monoamine transmission from monoamine
neurones leads to symptoms of depression whereas increased
transmission from monoamine neurones leads to symptoms of
mania (Schildkraut, 1965; Davis, 1970). This theory is,
however, derived from the rather circumstantial evidence
that drugs which influence mood, drive and motivation
- 4 -
change presynaptic biochemical evenis in a manner which
can lead to predictions about changes in synaptic trans¬
mission (Davis, 1970). More recently, changes in the
sensitivity of the postsynatpic membrane to the neuro¬
transmitter have been implicated in the aetiology of
affective disorders (MRC, 1972).
It has been proposed that the blockade of monoamine
uptake into nerve terminals by tricyclic antidepressant
drugs results in an increase in the monoamine concentra¬
tion at the post syne. ti.c receptor which, in turn, is ref¬
lected in an enhances effect of the monoamine (Iversen,
1965). It is assumed that this potentiation of mono¬
amine effects is responsible for the clinical effective¬
ness of imipramine and desipramine in the treatment of
depressive episodes (Schildkraut, 1965). It has been
suggested that the efficacy of tricyclic antidepressant
drugs in alleviating depression reflects the ability of
these drugs to inhibit the accumulation of monoamines
into nerve terminals (Iversen, 1974).
The pharmacology of the tricyclic antidepressant
drugs imipramine, desiprasiine and iprindole will there¬
fore be described with respect to their effects on mono¬
amine responses and their effects on the uptake of mono¬
amines into nerve terminals.
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1;3 THE PHARMACOLOGY OF TRICYCLIC ANTIDEPRESSANT DRUGS
According to Haflinger (1959), iminodibenzyl, the
parent compound of imipramine-like drugs, was synthesised
in 1899 by Thiel and Holzinger. Little attention was
paid to its pharmacology until 1948 when a number of deri¬
vatives were synthesised as potential antihistaminic agents
(Schindler & Haflinger, 1954), However, because of the
structural similarity to the phenothiazines, one deriva¬
tive, imipramine, was tested on schizophrenic patients.
There was no evidence of antipsychotic action, but Kahn
(1957; 1958) noted an elevation in the mood of patients.
Early studies on the metabolism of imipramine
resulted in the isolation of an N-demethylated derivative
desmethylimipramine (desipramine) by Herman and Puller
(1960). It was subsequently believed for some time that
desipramine was responsible for the clinical effectiveness
of imipramine (Brodie, Bickel & Sulser, 1961; Gillette,
Dingell, Sulser, Kuntzman & Brodie, 1961) but it was later
shown that imipramine did have a clinical antidepressant
action of its own (Hollister, Overall, Johnston, Katz,
Kimbel & Honigfeld, 1963; diMascio, Heninger & Klerman,
1964).
Iprindole, a clinically effective antidepressant
drug (Hicks, 1965; Johnson & Maden, 1967), differs from
the imipramine-type antidepressants in being an indole
with an eight-membered saturated third ring. This struc¬
tural change introduces pharmacological changes of parti¬
cular interest (see below).
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1:3,1 THE PERIPHERAL PHARMACOLOGY OF IMIPRAMINB AND
desipraminb
1:3.1.1. Interaction with monoamines and acetylcholine
in smooth muscle test systems
Both imipramine and desipramine potentiated the
response to exogenously applied NA of the cat nictitating
membrane (Sigg, 1959; Soffer & Gyermek, 1961; Sturman ,
1971). In larger doses, however, potentiation was not
seen; instead the responses to NA were antagonised by
imipramine and desipramine (Sigg, 1959; Schaeppi, 1960).
The potentiation of the response to NA was shown not to be
due to circulating catecholamines being released from the
adrenal medulla (Domenjoz & Theobald, 1959; Gyermek &
Soffer, 1961; Soffer & Gyermek, 1961).
Although imipramine itself has almost no direct
vasopressor action (Ryall, 1961; Cairncross, Gerschon &
Gus, 1963), the vasopressor action of NA could be poten¬
tiated by imipramine in the carotid and femoral arteries
of the cat and of the dog (Osborne & Sigg, 1960; Osborne,
1962). In the carotid artery of the cat, for example,
low doses (75 ^ag/kg) of imipramine potentiated the vaso¬
pressor responses to NA in vivo while high doses (15 mg/kg)
markedly diminished the vasopressor responses (Osborne &
Sigg, 1960).
Turker and Khairallah (1967) showed that desipra¬
mine could potentiate the contractile response of aortic
strips to NA whereas increasing the concentration of
desipramine abolished the response to NA. Toda (1971)
noted that the NA-induced contraction of pulmonary artery,
- 7 -
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as well as of aortic, strips was potentiated by 2.10 M
desipramines but antagonised by 10~ M desipramine.
H.rdina & Ling (1970) also reported a noradrenolytic
effeci in their investigation of the interaction between
desipramine and the NA-induced contraction of the isolated
perfused renal artery. Desipramine decreased both the maxi¬
mum and the slope of the log-dose-response curve to NA.
In the rabbit ear artery preparation, a low dose
—8
of desipramine (10 M) potentiated the response to NA
whereas a higher dose of desipramine (10~ M) abolished
the responses (Bassett, Cairncross, Hacket & Story, 1969;
McCulloch & Story, 1972). Similar results have been re¬
ported from studies in the vas deferens of the rat.
Desipramine potentiated the response of the vas deferens
to NA whereas at higher concentrations (10~^M), desip¬
ramine antagonised the response (Westfall, 1973).
The effect of tricyclic antidepressants has also
been studied on the responses of: smooth muscle preparations
to electrical stimulation of the sympathetic innervation.
Imipramine, in doses of 150-600 mg/kg, enhanced
the nictitating membrane contractions in response to stimu¬
lation of the preganglionic cervical sympathetic nerve
(Sigg, Soffer & Gyermek, 1963). However, Osborne and
Sigg (1960), using a dose range of 50 ».?;000 mg/kg imip-
ramine, could observe only a diminished electrically
evoked contraction of the nictitating membrane. Similarly,
Costa, Garattini and Valzelli (1960) and Schaeppi (1960)
could not observe potentiation of the nictitating membrane
response to electrical stimulation following imipramine.
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Later, however, Haefely, Hurlimann and Thoenen (1964) and
Sturman (1971) confirmed the observation of Sigg et al9
(L963) and reported that both imipramine and desipramine
were capable of potentiating the effects of electrical
stimulation of the sympathetic innervation of the nictita¬
ting membrane. Similarly, in rabbit aortic strips, trans¬
mural stimulation elicited a response which was potentiated
_7
by low doses of desipramine (2.10 M) but antagonised by
higher doses (10~6m) of desipramine (Toda, 1971). .
Imipramine and desipramine also modify responses of
smooth muscle preparations to 5HT and DA. Gyermek and
Possemato (1960) observed that responses of the cat nicti¬
tating membrane to 5HT could be potentiated by imipramine.
Similarly, Turker and Khairallah (1967) showed that desip¬
ramine could potentiate the responses of aortic strips to
5HT. Furthermore, increasing the concentration of desip¬
ramine abolished the responses to 5HT (Turker & Khairallah,
1967). It has been reported that both the pressor and
depressor responses to DA in vivo are potentiated by desip¬
ramine in the carotid arteries of the cat (Basset et al,
1969; Kadziewala & Popielarski, 1971), guinea pig, rabbit
(Kadziewala & Popielarski, 1971) and dog (Bble, 1964).
In an attempt to separate presynaptic and post¬
synaptic components of the interaction between tricyclic
antidepressant drugs and monoamine responses, many authors
have used smooth muscle preparations which have been
sympathetically denervated.
Gyermek and Possemato (1960) were the first to ob¬
serve that, in a sympathetically denervated preparation of
- 9 -
the cat nictitating membrane, imipramine failed to poten¬
tiate the response to NA. Similarly, Sturman, (1971) also
d v/ cvkjjl
reported that, in thereat nictitating membrane, both imip¬
ramine and desipramine failed to potentiate the effects of
NA. However, the contractile response of the nictitating
membrane to NA could still be antagonised by imipramine and
desipramine following denervation (Sturman, 1971). In
-9
the rabbit ear artery preparation, imipramine (10 M)
potentiated the contractile response to NA. However, in
the denervated preparation the same concentration of imip¬
ramine antagonised the response to NA instead (Callingham,
1967). In agreement with Callingham (1967), McCulloch and
Story (1972) reported that, following denervation, only
antagonism of the response to NA could be seen; potentiation
was never observed. Identical results have been reported
in the postganglionically denervated rat vas deferens
(Westfall, 1973).
It appears that denervation does not influence the
interaction between tricyclic antidepressant drugs and res¬
ponses to 5HT. Gyermek and Possemato (1960) have shown,
in a sympathetically denervated preparation of the cat
nictitating membrane, that, whereas the potentiation by imi¬
pramine of the response to NA disappeared, the response to
5HT could still be potentiated by imipramine.
It is well documented, then, that imipramine and
desipramine have a dual effect on responses to monoamines
of smooth muscle preparations; both potentiation and anta¬
gonism can be observed. Moreover, the dual effect of tri¬
cyclic antidepressant drugs on monoamine responses is dose-
- 10 -
dependent: lower doses potentiate and higher doses anta¬
gonise the response.
Turker and Khairallah (1967) concluded that the
inhibition of NA and 5HT responses could be explained on the
basis of a competitive <x-adrenergic blocking action of
desipramine. Scriabine (1969), however, proposed that desi-
pramine could compete with NA for both ■*- and ^-adrenergic
receptors. In contrast, Hrdina' and Ling (1970) concluded
that the antagonism of NA responses by desipramine was not
competitive in nature. They suggested that the action of
desipramine could be due to an interference with the action
of calcium in initiating and maintaining the contraction of
smooth muscle (Hrdinav & Ling, 1970).
It is more difficult, however, to interpret the
potentiation of monoamine responses. In the denervated
smooth muscle preparation, potentiation of responses to NA
by imipramine (Gyermek & Possemato, 1960) or desipramine
(Callingham, 1967) was never observed: antagonism only was
seen. It is likely, therefore, that an interaction bet¬
ween the tricyclic antidepressant drugs and a presynaptic
process mediates the potentiating effect. The inhibition
of monoamine uptake into nerve terminals by tricyclic anti-
depressant drugs (see below) may therefore be responsible
for the potentiation of monoamine responses. However,
even in the denervated smooth muscle preparation, responses
to 5HT can be potentiated by imipramine (Gyermek &
Possemato, 1960). It appears then that inhibition of mono¬
amine uptake into nerve terminals is not a complete explana¬
tion for potentiation.
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There is also evidence that tricyclic antidepressant
drugs interact, not only with monoamine responses but with
cholinergic responses as well (Domenjoz & Theobald, 1959).
A small dose of imipramine (1-3 mg/day) in cats diminished
the bradycardia which followed the stimulation of the peri¬
pheral cut vagus nerve (Sigg, 1959) and reduced the pilo¬
carpine induced salivation (Sigg, 1959; Sulser, Watts &
Brodie, 1961). Furthermore, in the isolated intestine,
imipramine blocked the effect of acetylcholine (ACh)
(Sigg, 1959). Osborne and Sigg (1960) reported that the
hypotensive action of ACh, and of peripheral stimulation
of the cut vagus nerve,on the blood pressure of cats was
potentiated by a low dose of imipramine (320^ug/kg).
However, higher doses decreased and finally blocked the res¬
ponse to vagal . stimulation, although the response to ACh
was unaffected. Similarly, imipramine and desipramine
(0.033-0.16ml:) when applied to the rat phrenic nerve-
diaphragm preparation, first enhanced, then depressed and
finally abolished the contractile response to stimulation
(Change & Chaung, 1972). The anticholinergic activity
has been assessed quantitatively on the guinea pig ileum
(Theobald, Buch, Kunz, Morpurgo, Stenger & Wilhelmi, 1964)
and rat stomach fundal strip (Atkinson & Ladinsky, 1972)
preparations.
There is evidence, then, to suggest that imipramine
and. desipramine may have a dual effect on responses to ACh
of peripheral test systems: both potentiation and anta¬
gonism can be observed. Moreover, it is possible that the
dual effect of tricyclic antidepressant drugs on responses
- 12 -
to ACh is dose -dependent: lower doses potentiate whereas
higher doses antagonise the response.
The antagonism of responses to ACh by imipramine and
desipramine has been interpreted as an antimuscarinic action
of these drugs (Domenjoz & Theobald, 1959; Atkinson &
Ladinsky, 1972). The potentiation of responses to ACh
is more difficult to explain. Osborne and Sigg (1960)
concluded that the potentiating effect of imipramine
on response s to ACh was due to the blockade of cholines-
terase, since they could demonstrate an inhibitory effect
of imipramine on serum cholinesterase.
1:3.1.2, Inhibition of monoamine uptake
The effect of tricyclic antidepressant drugs on
catecholamine uptake into nerve terminals has been studied
mainly in the perfused heart preparation whereas the inter¬
action with indolamine uptake has been studied using blood
platelets.
Following an intraperitoneal injection, Herrting,
Axelrod and Whitby (1961) noticed that imipramine markedly
3
affected the amount of H-NA which accumulated in the
heart, a$ well as in other tissues. Slices of heart were
3
shown to accumulate H-NA by a process which obeyed
Michaelis-Menten kinetics (Dengler, Spiegel & Titus, 1961;
Dengler, Michaelson, Spiegel & Titus, 1962). The uptake of
3
H-NA into such slices was inhibited by imipramine and
desipramine (Titus & Spiegel, 1962). Similarly, the iso¬
lated perfused rat heart accumulates NA by an active process.
The NA is accumulated into nerve terminals; this uptake
process is competitively inhibited by desipramine and
- 13 -
imipramine (Bergen & Iversen, 1965; Iversen, 1965). A
—B
desipramine concentration of 1.3,10" M is sufficient to
produce a 50% reduction in the accumulation of NA (Iversen,
3
1965). The accumulation of H-NA into isolated rat atria
and into the perfused guinea pig heart is also inhibited by
desipramine (Leltz & Stefano, 1970). It has been demons-
3
trated recently that the inhibition by desipramine of H-NA
accumulation into adrenergic nerves of the rabbit aorta is
competitive in nature (Maxwell, Ferris, Burcsu, Woodward,
"Ei-jig & Williard, 1974). Imipramine and desipramine also
3
competitively inhibit the uptake of H-NA into cat spleen
(Herrting et al, 1961; Dengler et al, 1961) and rat vas
deferens (Haggendal & Hanberger, 1967). Tuck, Hamberger
and Sjoqvist (1972), incubated rat irises in the plasma
from patients receiving imipramine therapy and found a re-
3
duction in the accumulation of H-NA with respect to
controls.
The uptake of 5HT into blood platelets is a high
affinity sodium dependent process (Born & Gillson, 1959;
Stacy, 1961; Sneddon, 1969). Furthermore, the uptake of
5HT into blood platelets is followed by an intracellular
storage of the amine in reserpine-sensi.tive storage
vesicles (Pletscher, 1968).
The uptake of 5HT into rabbit blood platelets is
inhibited by imipramine and desipramine (Siva-Sankar,
Borewka & Polinsky, 1964). There is some inconsistency in
the literature, however, concerning the potency of tricyclic
antidepressants in inhibiting the uptake of 5HT into
platelets. For example, Buczko, de Gaetano and Garattini
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(1974) reported that a desipramine concentration in the
-5 3
order of 10 M was required to reduce the uptake of H-5HT
_7
by half, whereas Stacy (1961) reports a figure of 5.10 M.
Lingjaerde (1970) reported a 91% inhibition of 5HT uptake
by an imipramine concentration of 10~ M, Tuomisto (1974)
credits these differing values of the antidepressant concen¬
tration to poor methodology of earlier studies and reported
that a 50% inhibition of 5HT uptake was obtained with con-
centrations of 10" M imipramine and 10" M deaipramine. The
inhibition was competitive in nature (Tuomisto, 1974).
The uptake of 5HT into human blood platelets is also
inhibited by imipramine (Marshall, Stirling, Tait & Todrick,
1960; Yates, Todrick & Tait, 1964; Todrick & Tait, 1969;
^.htee & Saarnvaara, 1971) and desipramine (Yates et al, 1964;
Todrick & Tait, 1969; Ahtee & Saarnvaara, 1971).
It has also been demonstrated that imipramine effec¬
tively blocks 5HT uptake in the rat heart (Iversen, 1965)
and aortic strips (Maxwell, Keenan, Chaplin, Roth & Eckhardt,
1969).
There is evidence, then, that monoamines are accumulated
into sympathetically innervated tissues and blood platelets
by an active process. This active process is competitively
inhibited by desipramine and imipramine0
1:3.2 THE CENTRAL PHARMACOLOGY OF IMIPRAMINE AND
DESIPRAMINE
1:3,2.1. Interaction with reserpine and amphetamine
The effects of tricyclic antidepressant drugs on the
central nervous system have, largely, been obtained by
studying the interaction of the tricyclic antidepressant
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drugs with reserpine and amphetamine effects.
As reserpine can produce severe depressive reactions
in man (Miller, 1955; Harris, 1957), reserpine, and
reserpine-like drugs were used extensively in animals to
produce a model condition of depression -which is amenable to
the testing of potential antidepressant drugs.
In animals, reserpine treatment results in ptosis or
blepharospasm and this can be transformed into a quantita¬
tive bioassay (Rubin, Maione, Waugh & Burke, 1957).
Reserpine treatment also results in sedation; there is a
decrease in locomotor activity and catatonia results
(Garattini & Jori, 1967). Imipramine prevents the ptosis
induced by reserpine in cats (Garattini, Giachetti, Fieri &
Re, 1960). Furthermore, the sedative effect of reserpine
in rats was also prevented by imipramine and desipramine
(Domenjoz & Theobald, 1959; Sulser, Watts & Brodie, 1960;
Cheu & Bohner, 1961). The antagonism of the sedative
action of reserpine by imipramine and desipramine has also
been demonstrated in mice (Askew, 1963; Aceto & Harris,
1965) and rabbits (Maxwell & Palmer, 1961).
The interaction between tricyclic antidepressant
drugs and reserpine has also been determined by measuring
the temperature changes induced by reserpine in rats.
When reserpine is given intravenously to rats it produces
changes of body temperature in two phases (Garattini &
Jori, 1967). An initial phase of hyperthermia lasting
for about twc hours, is followed by a marked hypothermia.
Imipramine and desipramine enhance the hyperthermia in¬
duced by giving reserpine intravenously to rats (Jori,
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Paglialunga & Garattini, 1966). However, if given prior
to reserpine, imipramine and desipramine prevent the hypo¬
thermia induced by reserpine (Garattini, Giachetti, Jori,
Pieri & Valzelli, 1962). In addition, a marked increase
in temperature was noted when imipramine was given to
reserpinised rats in the hypothermic phase (Garattini &
Jori, 1967).
In contrast to reserpine, amphetamine stimulates
locomotor activity and produces hyperthermia. Imipramine
and desipramine potentiate the effect of amphetamine on
motor activity in rats (Furginele, Aiamente & Horovitz,
1964). In addition, the amphetamine-induced hyperthermia
in rats and rabbits is potentiated by imipramine and desip¬
ramine (Morpurgo & Theobald, 1965).
In addition to its effects on motor activity, amphe¬
tamine also produces behavioural arousal (Stein & Sifter,
1961). In am operant conditioning reigirc, rats were
retarded with hypothalamic stimulation for pressing a lever.
Amphetamine enhanced this behaviour (Stein & Sifter, 1961).
These authors found that imipramine prolongs and augments
the rewarding effects of amphetamine with hypothalamic
stimulation.
1:3.2.2. Interaction with monoamine precursors
Most studies on the interaction between tricyclic
antidepressant drugs and monoamines were performed on
peripheral tissues. Data regarding the interaction bet¬
ween tricyclic antidepressant drugs and monoamines in the
central nervous system have been lacking until recently.
Monoamines do not pass the blood-brain barrier and thus do
- 17 -
not reach central receptor sites.
The blood-brain barrier has been circumvented in
studies using the monoamine precursors L-DOPA (3,4-
dihydroxy-L-phenylalanine) and 5HTP (5-hydroxytryptophan).
Thus it has been reported that the anti -reserpine effect of
L-DOPA is potentiated by imipramine (McGrath & Ketteler,
1963).
Imipramine also potentiates the 5HTP induced fever in
rabbits (Leow & Taeschler, 1965), which was interpreted as
a centrally mediated action.
This interaction between tricyclic antidepressant drugs
and 5HTP has also been investigated at the level of the
spinal cord where Anden, Jukes and Lundberg (1964) showed
that an increase in 5HT receptor activity results in the
potentiation of the hindlimb-extensor reflex of the cat.
Imipramine potentiated the effects of 5HTP as well as the
effect of tryptophan on the extensor-hindlimb reflex (Keek,
Fuxe & Anden, 1970). In a similar study, Sinclair and
Sastry (1974) noted that imipramine and desipramine blocked
the assumed serotinergic bulbospinal inhibition of the mono¬
synaptic reflex in the spinal cord. Fur the r more , following
an infusion of either antidepressant drug, the bulbospinal
inhibition was blocked, but later facilitation of the mono¬
synaptic reflex appeared (Sinclair & Sastry, 1974).
1:3.2.3. Effect on responses of single neurones to
monoamines and acetylcholine
The blood-brain barrier has also been by-passed by
studyinc the interaction of tricyclic antidepressant drugs
with monoamines at the level of the single neurone, using
- 18
the technique of microelectrophoresis.
In the cerebral cortex of the cat, both excitatory
and depressant responses to NA were affected by both imip-
ramine and desipramine (Bradshaw, Roberts & Szabadi , 1971a;
1974), Both potentiation and antagonism of the responses
could be observed following a brief application of the anti¬
depressant. Low doses resulted in potentiation of the res¬
ponses whereas higher doses resulted in antagonism of the
responses to NA (Bradshaw et al, 1974),
Avanzino, Ermirto and Zummo (1971) studied the inter¬
action between imipramine and NA in the brain stem of the
guinea pig. When imipramine and NA were applied simul¬
taneously the size of a response to NA was larger than when
NA alone was applied. Although imipramine did have a
direct agonistic action on some neurones, the enhancement
was interpreted as a potentiation of the NA response by
imipramine. When imipramine was applied for some time
before NA, no enhancement, but often a reduction, in the
size of the respone« to NA could be observed, Desipramine
has been shown to potentiate responses to NA of Purkinje
cells (Hoffer, Siggins & Bloom, 1971). Similarly to NA
both excitatory and depressant responses to 5HT could be
potentiated and antagonised by the tricyclic antidepressant
drugs (Bradshaw et al, 1971a; 1974.).
The interaction between tricyclic antidepressant drugs
and ACh in the central nervous system has only recently
received attention. Using the microelectrophoretic
technique, it was demonstrated that excitatory responses of
single cortical neurones to ACh could be modified by imip-
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ramine and desipramine (Bradshaw et al, 1971a; Bevan,
Bradshaw, Roberts & Szabadi, 1973c; Bevan, Bradshaw &
Szabadi, 1975a). As with monoamines (Bradshaw et al,
1974) both antagonism and potentiation of the responses to
ACn could be observed. Antagonism of the response occurred
at higher doses than potentiation (Bevan et al, 1973c;
1975a).
Thus it has been demonstrated in the central nervous
system that, as in the peripheral nervous system, imipramine
and desipramine have a dual effect on responses to mono¬
amines and ACh: both potentiation and antagonism can be
observed. Moreover, the dual effect of tricyclic antidep¬
ressant drugs on responses to monoamines and ACh is dose-
dependent: lower doses potentiate whereas higher doses
antagonise the response.
1:3.2.4. Inhibition of monoamine uptake
The interaction between tricyclic antidepressant drugs
and monoamine uptake in. the brain has been studied using
biochemical and histochemical techniques to follow the
accumulation of radiolabelled monoamines into whole brain.
Carlsson, Fuxe, Hamberger and Lindqvist (1966) deter¬
mined the effect of desipramine on the accumulation of HA
and DA in the brain following the administration of L-DOPA.
Rats were pretreated with reserpine, to deplete monoamine
stores, and with nialamide, to prevent peripheral metabo¬
lism of L-DOPA. Desipramine (10 mg/kg i.p) prevented the
accumulation of NA into the brain following the adminis¬
tration of L-DOPA. The uptake of DA was apparently not
affected. In another study, NA, DA or 5HT was injected
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into the lateral ventricles of reserpine pretreated rats
(Fuxe & Ungerstedt, 1968). Desipramine inhibited the
accumulation of NA into nerve terminals adjacent to the
ventricles. In contrast to the observations in the report
of Carlsson et al, (1966), DA accumulation was also reduced
"whereas 5HT was not affected.
The uptake of catecholamines"1 has been studied using
both slices and synap to somes prepared from various regions
of the brain. There is a highly active catecholamine
transport system into both dopaminergic neurones and into
noradrenergic neurones (Snyder & Coyle, 1969). Therefore
the striatum has often been used as a dopaminergic uptake
system whilst the cerebral cortex or hypothalamus has been
used as a noradrenergic uptake system (Ross & Renyi, 1967;
1969; Ross et al, 1971; Horn, Coyle & Snyder, 1971).
3
The uptake of H-NA into slices of cerebral cortex
of the mouse (Ross & Renyi, 1967) and rat (Haggendal &
Hamberger, 1967; Saloma, Insalaco & Maxwell, 1971) and
into slices of the midbrain of the mouse and rat (Ross et al,
1971) was inhibited by imipramine and desipramine. The
inhibition was competitive in nature (Saloma et al, 1971)
and was completely inhibited by an imipramine concentration
of 10~5M (Haggendal & Hamberger, 1967; Ross et al, 1971).
Similar results have been obtained using synaptosome prepa¬
rations. In the cerebral cortex, Maxwell et al (1974)
have shown that desipramine competitively inhibits the up¬
take of 3H-NA. Furthermore, desipramine and imipramine
3




Similar to NA, the uptake of H-DA into hypothalamic
synaptosomes was competitively inhibited by both imipramine
and desipramine (Horn et al, 1971).
In contrast to their effects on catecholamine uptake
in the cerebral cortex and hypothalamus, imipramine and
3
desipramine haxdly affected the accumulation of H-NA or
3
H-DA into striatal synaptosomes. Imipramine was 100
times less potent, and desipramine 1000 times less potent
in inhibiting the accumulation of NA and DA into striatal
synaptosomes, as compared with hypothai semi c synaptosomes
(Horn et al, 1971). Similarly, Ross et al, (1971) and
Haggendal and Hamberger (1967) reported that the uptake of
3
H-DA into slices of striatum was not affected by
desipramine.
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The uptake of H-5HT (Ross & Renyi, 1969) and C-
5HT (Ross et al, 1971) into slices prepared from the mouse
cosebra" cortex was competitively inhibited by both imip¬
ramine and desipramine. Furthermore, the administration
of imipramine or desipramine in vivo decreased the capacity
3
of the tissue to accumulate H-5HT when subsequently exa¬
mined in vitro (Ross & Renyi, 1969; Carlsson, 1970).
3
The accumulation of H-5HT into brain slices was also inhi¬
bited when the incubations were performed using plasma from
patients receiving imipramine treatment (Hamberger & Tuck,
1973). The uptake of ^H-5HT into rat forebrain synapto¬
somes is also inhibited by imipramine (Kuhar, Roth &
Aghajanian, 1972).
There is evidence then, that monoamines are actively
accumulated into nerve terminals in the brain. In the
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cerebral cortex, the accumulation of NA, 5HT and DA is
competitively inhibited by imipramine and desipramine.
Similarly, the uptake of NA and DA into nerve terminals
in the hypothalamus can be inhibited by both imipramine and
desipramine. In contrast, neither imipramine nor desip¬
ramine inhibited the uptake of NA and DA into nerve ter¬
minals in the caudate nucleus.
1:3.3 THE PHARMACOLOGY OF IPRINDOLE
The striking difference between the pharmacology of
iprindole and other tricyclic antidepressant drugs is that
iprindole is almost completely without any monoamine uptake
blocking activity. For example, iprindole has little
3
effect on the uptake of H-NA into the heart or into brain
tissue in vivo. Whereas 5 mg/kg imipramine inhibited the
uptake of i\A by 50% in both tissues, 50 mg/kg iprindole
achieved only a 12% inhibition of NA uptake (Gluckman &
Baum, 19 69). Iprindole (15 mg/kg) did not alter the "^H-NA
accumulation into rat heart (Lemberger, Serratinger &
Kuntzman, 1970); indeed, no effect on catecholamine uptake
into rat heart could be detected with iprindole concentra¬
tions as high as 200 mg/kg (Lahti & Maickel, 1971).
Rosloff and Davis (1974) injected ^H-NA intracisternally
and could not find any effect of iprindole on the accumu¬
lation of radioactivity into the rat brain. They also
examined the effect of iprindole on the uptake of DA into
striatal synaptosomes and the uptake of NA and 5HT into
synaptosomes from the rest of the brain (whole brain minus
the striatum). No effect of iprindole on the uptake of
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the monoamines could be detected (Rosloff & Davis, 1974).
Like imipramine, iprindole antagonises the reserpine-
induced ptosis in mice, and also reverses the reserpine-
induced hypothermia (Gluckman & Baum, 1969). Iprindole
also reverses the loss of appetite induced in rats by amphe¬
tamine (Gluckman & Baum, 1969) and enhances and prolongs the
psychomotor stimulation produced in rats by amphetamine
(Miller, Freeman, Dingell & Sulser, 1970). The pressor
response of the dog femoral artery to NA is potentiated by
iprindole (Gluckman & Baum, 1969). Similarly, the NA-
induced increase in the blood pressure of rabbits is poten¬
tiated by iprindole, although only antagonism of the NA-
induced contraction of rabbit aortic strips could be ob¬
served (Saarnvaara & Mattila, 1974). The interaction bet¬
ween iprindole and NA pressor effects has also been studied
in humans (Fann, Davis, Janowsky, Kaufmann, Cavanaugh &
Oats, 1974). In five patients diagnosed as depressed, NA-
induced pressor-response curves were constructed. Iprin¬
dole, in doses of 60 mg and 120 mg, did not change the NA-
induced blood pressure response (Fann et al, 1974).
The effect of iprindole on responses to ACh has re¬
ceived little attention. Gluckman and Baum (1969) reported
that the response of the guinea pig ileum to ACh was
inhibited by iprindole.
Iprindole shares with imipramine and desipramine the
ability to antagonise the effects of reserpine and enhance
the effects of amphetamine. Furthermore, iprindole poten¬
tiates the responses to NA of sympathetically innervated
tissues. These observations are particularly interesting
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as it has been shown that iprindole toes not share with
other tricyclic antidepressant drugs the ability to inhibit
the accumulation of monoamines into nervous tissue.
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1:4 MICROELECTROPHORESIS
Monoamine transmission forms the basis of many current
theories of the mode of action of psychoactive drugs, inc¬
luding the tricyclic antidepressants (Davis, 1970), the
neuroleptics (Stein, 1971) and the hallucinogens (Brawley
& Duffield, 1972). Many of the interactions between psycho¬
active drugs and monoamine transmitters can be studied at
the level of the single brain cell using the technique of
microelectrophoresis.
The microelectrophoretic technique consists of the
ejection into the extraneuronal space of pharmacologically
active drugs as ions from glass micropipettes, and of the
simultaneous recording of extracellular action potentials.
The site of drug action is thus restricted to the immediate
vicinity of the neurone under observation. The blood-
brain barrier is, then, circumvented allowing the inter¬
action between psychoactive drugs and putative neorotrans-
mitters to be tested directly on single neurones in the
bra in.
The experiments reported in this thesis used this
technique to examine the effect of tricyclic antidepressant
drugs on responses of single caudate and cortical neurones
to monoamines and ACh. Previous reports on the effects of
microelectrophoretically applied monoamines and ACh, on





Krnjevic and Phillis (1963) investigated the responses
of cortical neurones to NA in the barbiturate-anaesthetised
cat. On these cells, which were activated by L-glutamate
or DL-homoscysteate, NA had a predominantly depressant action,
although excitatory responses were observed when higher
currents were used. Johnson, Roberts & Straughan (1969b)
confirmed that, when barbiturate anaesthesia was used, the
predominant effect of NA was depression, but pointed out
that in encephale isole preparations cortical neurones
responded to NA more frequently with excitation.
Johnson, Roberts, Sobieszek & Straughan (1969a) were
careful to control for the possible effects of hydrogen ions
released from the micropipette during the application of NA.
They reported that NA released from solutions at pH 3 had
identical effects to NA released from solutions at pH 5.
They concluded that hydrogen ions were unlikely to contribute
to the observed responses to NA. However, these findings,
confirmed later by Stone (1972), were disputed by
Frederickscn, Jordan & Phillis (1971). They argued that NA
was exclusively depressant when released from solutions whose
pH was greater than 4 whereas excitatory responses were
encountered when solutions of pH 3 or less were used. Sub¬
sequently it was reported that hydrogen ions, released from
solutions of HC1 could also excite cortical neurones (Jordan,
Lake & Phillis, 1972a). These authors thus argued that the
true action of NA on cortical neurones is inhibitory.
The effect of NA on cortical neurones was subsequently
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re-examined (Bevan, Bradshaw, Roberts & Szabadi , 1973a).
The. responses of cortical neurones to NA released from solu¬
tions at pH 3.1 and pH 5.0, and the effect of hydrogen ions
released from HC1 were compared. Each cell excited by NA
(pH 3.1) was also excited by NA (pH 5.0); similarly, each
cell depressed by NA (pH 5.0) was also depressed by NA
(pH 3.1). One cell responded to hydrogen ion application,
and that response was a depression. When released from
a solution at pH 3. 1, NA usually evoked a larger response
than when released from solutions at pH 5.0 (Bevan et al,
1973a). This was attributed to a reduction in the transport
number of NA as the pH of the solution is raised by the addi¬
tion, of NaOH. ' This was subsequently confirmed by in vitro
studies (Bevan, Bradshaw, Roberts &.Sz&.badi, 1973b).
Recent reports have also demonstrated both excitatory
and depressant responses to NA in the cerebral cortex of the
cat (Fr.ederickson, Jordan & Phillis, 1972; Bevan et al,
1974a), the rat (Stone, 1973a) and the rabbit (Giardina,
Pedemente & Sabelli, 1972).
Excitatory responses to NA could be antagonised by the
rx-adrenoceptor antagonists phentolamine, dibenamine and
thymoxamine, and by the (^-adrenoceptor antagonists propranolol,
sotalol and isopropylaminonitrophenylethanol (INPEA)
(Johnson et al, 1969^0, whilst depressant responses were
rarely affected. The antagonisms were specific in that
excitatory responses to ACh were not affected (Johnson et al,
1969a). Frederickson et al (1972) demonstrated that dep¬
ressant responses to NA could be antagonised by the adrener¬
gic blockers dibenamine, phentolamine, phenoxybenzamine and
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INPEA. Excitatory responses to NA, which these authors
attributed to the depression of a nearby inhibitory
neurone, were also antagonised by dibenamine, phenoxy-
benzamine and phentolamine. Depressant responses to NA
could also be antagonised by bulbocapnine (Anderson &
Stone, 1974) and also by strychnine (Yarbrough, Lake &
Phillis, 1974). In an earlier report (Stone, 1973a)
however, no effect of strychnine on NA depression could
be found.
Recently it has been reported that responses to NA
can be potentiated by sotalol (Bevan, Bradshaw & Szabadi,
1974b). Excitatory responses to NA were potentiated when
the sotalol was ejected with a low current, but poten¬
tiation was superseded by antagonism when the intensity
of the ejecting current was increased. Excitatory res¬
ponses to NA were affected in a similar manner by methy-
sergide: both potentiation and antagonism could be ob¬
served (Bevan et al, 1974b). Responses to ACh were not
affected by sotalol or methysergide.
Cyclic AMP, and dibutyryl cyclic AMP, had either no
effect or only weak depressant action on cortical neurones
which were depressed by NA (Jordan, Lake & Phillis, 1972b;
Lake, Jordan & Phillis, 1973). Phosphodiesterase
inhibiting drugs, such as aminophylline and papaverine,
enhanced the depression produced by NA, but were reported
to have depressant actions of their own (Lake et al, 1973).
Calcium antagonists have been observed to antagonise
the depressant effects of NA on cortical neurones. Lanthanum,
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Verapamil and manganese antagonised depressant responses
of cortical neurones to NA (Yarbrough et al, 1974).
Similarly, ethanol, cocaine, procaine and lidocaine
(Yarbrough et al, 1974) as well as neomycin and ruthenium
red (Phillis, 1974) antagonised the inhibitory action of
NA on cortical neurones.
A recent series of experiments have investigated the
interaction between the tricyclic antidepressant drugs
imipramine and desipramine, and the responses of single
cortical neurones to NA (Bradshaw et al, 1971a; 1974).
Both imipramine and desipramine can modify both excitatory
and depressant responses to NA. A small dose of either
antidepressant drug potentiated the response whereas a
larger dose usually antagonised the response to NA
(Bradshaw et al, 1974).
1:4.1.2. 5-hydroxytryptamine
The effects of 5HT on single neurones in the cerebral
cortex were investigated by Krnjevic & Phillis (1963).
These authors observed both excitatory and inhibitory res¬
ponses to 5HT. As with NA, there was a predominance of
depressant responses. Roberts & Straughan (1967) could
also observe both excitatory and depressant responses of
single cortical neurones to 5HT, but in contrast to
K.rn;:evic & Phillis (1963), observed mainly excitatory res¬
ponses. Johnson et al, (1969b) criticised the use of
barbiturate anaesthesia by Krnjevic & Phillis (1963).
Johnson et al (1969b) showed that, in barbiturate
anaesthetised preparations, 5HT evoked largely depressant
responses. In contrast, in encephale isole or halothane
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anaesthetised preparations, 5HT had a predominantly
excitatory effect on single cortical neurones (Johnson
et al, 1969b).
Later reports have demonstrated both excitatory and
depressant responses to 5HT in the cerebral cortex of the
cat (Bradshaw et al, 1971a; 1974; Bevan et al, 1974a)
and rat (Stone, 1974).
Excitatory responses to 5HT could be reversibly an¬
tagonised by LSD, BOL, methysergide and cinanserin
(Roberts & Straughan, 1967) xvhereas depressant responses
to 5HT and excitatory responses to ACh were unaffected
(Krnjevic & Phillis, 1963; Roberts & Straughan, 1967).
Similarly, neither excitatory nor depressant responses to
5HT were affected by the adrenergic antagonists phentolamine
and sotalol (Johnson et al, 1969a). However, Frederickson
et al (1972) reported that depressant responses to 5HT
could be antagonised by the adrenergic antagonists phen¬
tolamine , phenoxybenzamine and INPEA.
It has recently been reported that excitatory responses
to 5HT can be potentiated by ^ethysergide (Bevan et al, 1974b).
Excitatory responses to 5HT were potentiated when methy¬
sergide was ejected with a low current, but the poten¬
tiation was superseded by antagonism when the intensity of
the ejecting current was increased. Excitatory responses
to 5HT were affected in a similar manner by sotalol: both
potentiation and antagonism could be observed (Bevan et al,
1974b). Strychnine antagonised the depressant action of
5HT on neurones identified as pyramidal tract neurones
(Stone, 1973a).
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Lanthanum, verapamil and manganese antagonise the dep¬
ressant effects of 5HT on cerebral cortical neurones
(Yarbrough et al, 1974). Similarly, ethanol and the
anaesthetic agents cocaine, procaine and lidocaine
(Yarbrough et al, 1974) as well as neomycin and ruthenium
red (Phillis, 1974) antagonised the inhibitory actions of
5HT on cerebral neurones. These diverse agents seem to
share only rhe ability to interfere with calcium
metabolism (Yarbrough et al, 1974).
The tricyclic antidepressant drugs imipramine and
desipramine could modify both excitatory and depressant
responses to 5HT (Bradshaw et al, 1971a; 1974). Small
doses of imipramine or desipramine potentiated responses
whereas larger doses antagonised responses to 5HT.
Imipramine proved to be more potent than desipramine in
modifying responses to 5HT, whereas the converse was true
with respect to NA responses (Bradshaw, Roberts & Szabadi,
1973$).
1:4.1.3. Dopamine
DA was originally reported to cause a short latency
depression of both spontaneous and amino-acid induced firing
of cortical neurones (Krngevic & Phillis, 1963). More
recent reports have demonstrated excitatory responses of
cortical neurones to DA. For example, Stone (1973b) re¬
ported both excitatory and depressant responses to DA in
the cerebral cortex of the halothane and urethane
anaesthetised rat.
Both excitatory and depressant responses of single
cortical neurones to DA could be antagonised by chlor-
promazine (Stone, 1974; Stone & Bailey, 1975).
- 3 2 -
1:4.1.4. Mescaline
Krnjevic and Phillis (1963) reported that the exc¬
lusive action of mescaline on single neurones in the
cerebral cortex of the cat was one of depression. In
contrast, Roberts and Straughan (1968) reported that
mescaline could evoke both excitatory and depressant res¬
ponses when applied to cortical neurones. This was con¬
firmed later by Bradshaw, Roberts & Szabadi (1971b) who
pointed out the high correlation betweai the effects of
mescaline and NA. Furthermore, cross-desensitisation
between the responses to mescaline and NA ha s been demo-
h
nstrated, although it did not appear to, specific as res¬
ponses to 5HT and ACh were often affected as well (Bevan
et al, 1974a). The effect of mescaline on responses to
NA and 5HT was also studied on cells which did not respond
to mescaline (Bevan et al, 1974a). The simultaneous
application of mescaline resulted in antagonism of excita¬
tory responses of single cortical neurones to NA and 5HT.
Excitatory responses to mescaline could be antagonised
and potentiated by sotalol and methysergide (Bevan et al,
1974b). When the antagonist was applied with a low ejec¬
ting cuirent, the response to mescaline was potentiated.
This potentiation was superseded by antagonism when the
intensity of current ejecting the antagonist was increased.
Responses to ACh were not affected. Depressant responses
to mescaline were antagonised by methysergide, but not by
sotalol, although the number of cells tested was small
(Bevan e t al, 19 74b).
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1:4.1.5. Acetylcholine
Krnjevic (1964) reported that the predominant effect
of ACh on cortical neurones was one of excitation. Other
reports however, have demonstrated depressant responses to
ACh of cortical neurones in the cat (Spehlmann, 1563;
Randic, Giminoff & Straughan, 1964; Crawford & Curtis,
1966) and in the rat (Stone, 1972). The response of a
neurone to ACh was antagonised by intravenous injection
of a small dose of barbiturate, urethane or chloralose
(Crawford & Curtis, 1966).
Excitatory responses to ACh could be reversibly anta¬
gonised by atropine (Krnjevic & Phillis, 1961; Crawford
& Curtis, 1966; Bevan, Bradshaw & Szabadi, 1975b) and
hyoscine (Krnjevic & Phillis, 1962; Crawford & Curtis,
1566). Bevan et al (1975b) demonstrated that atropine
shifted the cur rent-response curve for ACh to the right
in an approximately parallel fashion, indicating a com¬
petitive antagonism of ACh responses by atropine. A dose-
ratio of 12 was obtained in these experiments. Clarke,
Forrester and Straughan (1974) constructed cumulative dose-
response curves on the basis of single applications of ACh.
These curves were displaced to the right in an approxi¬
mately parallel fashion in the presence of atropine.
Stone (1972) reported that ACh could evoke excitatory, but
not depressant, responses when applied to identified pyra¬
midal tract neurones in the cortex. Non-pyramidal tract
neurones were excited or depressed by ACh. Furthermore,
atropine and hyoscine could antagonise both excitatory and
depressant responses to ACh.
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Excitatory responses to ACh were potentiated by the
cholinesterase inhibitors neostigmine and edrophonium
(Krnjevic & Phillis 1962).
Recently, the interaction between excitatory responses
to ACh and the tricyclic antidepressants imipramine and
desipramine has been investigated (Bevan, Bradshaw &
Szabadi, 1973a; 1975a). Imipramine and desipramine
could both potentiate and antagonise excitatory responses
to ACh; lower doses potentiated whereas higher doses
antagonised the responses. Excitatory responses to car -
bachol were affected in a similar way indicating that poten¬
tiation was not due to inhibition of cholinesterase
activity. Atropine was also shown to have a dual effect
on excitatory responses to ACh (Bevan et al, 1973c; 1975a).
Similarly to imipramine and desipramine, low doses of
atropine potentiated whereas higher doses antagonised the
responses to ACh.
Neither tubocurarine nor dihydro-p -erythroidine was
an effective antagonist of ACh excitations (Crawford &
Curtis, 1966); however, ACh depressions could be antagonised
by tubocurarine and dihydro-p -erythroidine as well as by
atropine and hyoscine (Phillis & York, 1967). Depressant
responses were also antagonised by strychnine (Jordan &
Phillis, 1972), although these results were not confirmed
(Stone, 1972). It has also been reported that the depres¬
sant responses of cortical neurones to ACh can be antago¬





In the caudate nucleus of the cat, McLennan and York
(1967) reported that DA could both excite and depress
neurones. Most cells were induced to fire by the applica¬
tion of excitant amino acids (L-glutamate or dl-homocysteic
acid) and few spontaneously active neurones could be found.
Later Herz and Zieglgansberger (1968) reported that the
only response to NA of single neurones in the caudate nucleus
was that of depression. Woodruff, Elkhawad, Crossman and
Walker (1974) also reported only depressant responses to DA.
It is well documented, however, "that DA cam evoke both
excitatory and depressant responses when applied to single
neurones in the caudate nucleus. For example, Connor (1970)
could observe excitatory and depressant responses to DA in
the unanaesthetised cat, and similar findings have been re¬
ported in the urethane (Gonzalez-Vegas, 1974), Penthrane
(Spencer & Havlicek, 1974) and halotnane (Siggins, Hoffer &
Ungerstedt, 1974) anaesthetised rat. Similarly, excitatory
and depressant responses, as well as biphasic responses (con¬
sisting of an initial depression followed by an excitation)
have been reported in the caudate nucleus of the squirrel
monkey (York, 1972) and in the putamen of cats (York, 1970).
The (Xr^dr ener gic antagonist phenoxybenzamine , but not
the y^-adxenergic antagonist dichloroisopropyl noradrenaline,
antagonised both excitatory and depressant responses to DA
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(McLennan & York, 1967; York, 1967). Excitatory, dep¬
ressant and biphasic responses to DA could also be antago¬
nised by chlorpromazine (York, 1970; 1972) phentoleonine
and sotalol (York, 1970). It has also been reported that
depressant responses to DA can be antagonised by papaverine,
bulbocapnine (Gonzalez-Vegas, 1974) and c<-methyldopamine
(Connor, 39 70).
The phosphodiesterase inhibitors aminophylline, and
l-methyl,3 iso-butyl xanthine potentiated the depressant
effects of DA (Siggins et a 1, 1974). In addition, these
authors showed that, in contrast to Gonzalez-Vegas (1974)
papaverine could also potentiate the depressant effects of
DA (Siggins et al, 1974).
1:4.2.2. Noradrenaline
NA, when applied to single spontaneously active
neurones in the caudate nucleus of the cat, evoked both
excitatory and depressant responses (Salmoiraghi &
Stefanis, 1965; Bloom, Costa & Salmoiraghi, 1965). In
contrast Herz and Zieglgansberger (1968) reported ex¬
clusively depressant effects of NA on spontaneously active
cells, and cells induced to fire by excitant amino acids
in the caudate nucleus of the rabbit. Excitatory and
depressant responses to NA have been reported in the putamen
of the cat (York, 1970) and in the caudate nucleus of the
rat (Spencer & Havlicek, 1974).
Excitatory responses to NA could be antagonised by
the ^'-adrenergic antagonist phentolamine and depressant
responses were antagonised by the f-adrenergic antagonists
INPEA and sotalol (York, 1970).
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1:4.2.3. 5-hydroxytryptamine
Both excitatory and depressant responses of single
neurones to 5HT have been observed in the caudate nucleus
of cats (Salmoiraghi & Stefanis, 1965) and in the putamen
of cats (York, 1970). Excitatory responses to 5HT could
be antagonised by phentolamine, whereas depressant responses
were antagonised by sotalol.
1:4.2.4. Acetylcholine
In the unanaesthetised decerebrate cat, ACh evoked
both excitatory and depressant responses when applied
to spontaneously active neurone s in the head of the caudate
nucleus (Bloom et al, 1974). Cells induced to fire by
the application of glutamate were invariably depressed by
ACh. In agreement with Bloom et al (1974) Salmoiraghi and
Stefanis (1965) and McLennan and York (1966) could observe
both excitatory and depressant responses to ACh in un¬
anaesthetised encephale isole preparations. Atropine,
but not hexamethonium, was able to antagonise both excita¬
tory and depressant responses to ACh (McLennan & York,
1966; York, 1970). Later, however, York (1970) reported
that depressant responses to ACh could be antagonised by







The technique of microelectrophoresis involves the
use of small electrical currents to expel minute quan¬
tities of drugs from fine micropipettes into the tissue
(Curtis, 1964).
2:1.1 MANUFACTURE OF MICROPIPBTTBS
Micropipettes were manufactured from Pyrex glass
capillary tubing (1.5 mm diameter, 1.00 mm bore) using a
modification of the method described by Herz, Wickelmaier
and Nacdemiento (1965). The glass was cut to a uniform
length (approximately 100 mm). Six pieces were bundled
together and smeared with "Araldite" (CIBA) at each end.
A brass ring was then placed over each end of the tubes
and the completed assembly, or blank, heated in an oven
(100°C; 30 min). The six glass capillary tubes were
thus securely bound to each other, and to the brass rings,
by the adhesive. To ensure that the blank was clean
(see 2:1.2), the blank was washed in chromic acid, followed
by two distilled water rinses and oven drying.
Two multibarrelled micropipettes were made from each
blank using a locally made machine (see Fig 1). The brass
rings at the end of each blank were securely clamped in
4" chucks so that the blank was held vertically with the
heating coil around the centre of the glass (Fig 1). The
heating coil was made from Nichrome wire and heated by a
current from a 6V DC source. The glass at the centre of
the blank was softened by switching on the heating coil,
and, whilst keeping the top chuck stationary, the bottom




PIG. 1. Photograph of the Puller used to manufacture the
micropipettes used in these experiments. See text (2:1.1) for
details.
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switched off. This procedure fused the individual glass
pipettes of the blank together so that the blank was secure
at the centre as well as at either end. After the glass
had cooled, the heating coil was repositioned at the
centre of the twisted glass and switched on.
As the glass softened, the bottom chuck pulled the
two brass rings apart drawing the glass capillaries out
until the y separated. Thus each chuck held a six-barrelled
glass micropipette. The overall tip diameter of micro-
pipettes produced in this way was less than 1 ^jam.
2:1.2 FILLING OF MICROPIPETTES
The individual capillaries, or barrels, of a micro¬
pipette were filled with aqueous solutions of the drugs
whose effects were to be studied. Two barrels were
always filled with 4M NaCl solutions for the recording
of extracellular action potentials (see 2;3.1) and for
current balancing (see 2:3.2.4).
Great care was taken to ensure that everything used
for manufacturing micropipettes was clean and dust free,
as the tips of micropipettes can be easily blocked or
obstructed. Thus the glass used for manufacturing micro¬
pipettes was thoroughly washed with chromic acid, and drug
solutions used for filling micropipettes were centrifuged
(1500 g; 30 min) immediately before use to sediment any
dust particles.
Two methods of filling micropipettes were used.
2:1.2.1. Dif fusion
This method, described by Curtis (1964), involved
two processes. First, the air in the barrels of the
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micropipette had to be displaced with distilled water,
and second, the water in each barrel of the micropipette
had to be replaced with the appropriate drug solution.
The micropipette, secured so as to protect the deli¬
cate tip, was immersed in a beaker of double glass dis¬
tilled water at 80°C. The beaker, in turn, was placed
in a sealed chamber from which the air was then evacuated
so that the water in the beaker boiled gently for about
20 min. This forced the air out of the micropipette
barrels, including the air in the narrow bore of the very
tip of the barrels, and replaced the air with distilled
water. The water was then removed from each barrel of
the micropipette down to the level of the shank using a
thin Portex tube and a syringe. The barrel was then
filled with a solution of the appropriate drug using a
thin Portex tube. Care was taken not to introduce air
bubbles into the barrels during this process. After
filling, the micropipettes were stored for 36 hr before
use to allow the drug molecules to diffuse into the tips
of the barrels. To inhibit oxidation of drugs during
this time, micropipettes were stored at 4°C in a nitrogen
atmosphere.
Immediately before use, the tip of a micropipette
was broken under microscopic control by bumping the tip
against a glass rod. The overall diameter of the micro¬
pipette tip after breaking varied between 3 and 6 yum;
this gave a DC resistance of the recording barrel of
between 2 and 5 megohms, when measured with the tip
immersed in 0.9% NaCl solution.
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An advantage of this technique of micropipette
filling is that the micropipettes can be prepared in
advance and in sufficient numbers to serve several
experiments. Thus experiments can proceed as soon as
the experimental animal has been prepared. However,
the necessity of storing filled micropipettes to allow
diffusion to occur would be a disadvantage if drugs of
an unstable nature were involved.
2:1.2.2. Cent rifuqa ti on
In this method, described by Curtis (1964), drug
solutions were forced into the tips of the micropipette
by using high centrifugal forces.
First the tips of the empty mxcropipettes were broken
under microscopic control to give an overall tip diameter
of about 4 (see above). Using thin Portex tubes,
each barrel of the micropipette was then filled with the
appropriate drug solution and the micropipette clamped
into a centrifuge tube. The micropipette was then centri-
fuged for 30 min at 1500 g. The micropipettes were then
ready for use.
As the micropipette tip was broken before being filled
with solutions, some of the drug solution could leak from
micropipettes filled by centrifugation. Micropipettes
filled in this way were thus not suitable for storage;
micropipettes would have to be prepared fresh for each
exper iment.
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2:2 PREPARATION OF EXPERIMENTAL ANIMAL
The microelectrophoresis experiments described in
this thesis were performed on rats. Many of the experi¬
ments involved the study of single neurones in the caudate
nucleus where rats offered several advantages over other
experimental animals eg cats. The caudate nucleus in rats
lies approximately 2.5 mm below the surface of the brain
and can thus easily be reached by introducing a 6-barrelled
micropipette through the cortex. Thus there is no surgi¬
cal intervention on the brain and no brain tissue has to be
removed eg. the overlying cerebral cortex (see McLennan &
York, 1966). Thus the physiological integrity of the
brain was preserved as much as possible.
Experiments were performed on male albino Wistar rats
weighing between 250 and 300 g.
2:2.1 ANAESTHESIA
Halothane anaesthesia was routinely used in all
experiments described in this thesis.
The choice of anaesthetic is crucial in micro¬
electrophoresis experiments as some anaesthetics can alter
the sensitivity of neurones to putative neurotransmitter
agents (Curtis, 1964). It has been shown, for example,
that, compared to unanaesthetised preparations, barbiturate
anaesthesia significantly reduced the proportions of excita¬
tory responses of single neurones to ACh in the cerebral
cortex, caudate nucleus (Bloom et al, 1965) and brain stem
(Bradley & Dray, 1973). Similarly, in barbiturate anaes¬
thetised preparations, excitatory responses to monoamines
of single neurones in the cerebral cortex (Johnson et al,
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1969b) and caudate nucleus (Spencer & Havlicek, 1974) are
almost absent. Using halothane anaesthesia however , both
excitatory and inhibitory responses of single neurones to
monoamines (Roberts & Straughan, 1967; Johnson et al,
1969b) and to ACh (Crawford, 1970) may be observed.
Furthermore, whereas pentobarbitone reduces the glutamate
sensitivity of neurones, halothane (1%) has no effect
(Richards & Smaje, 1974). Moreover, being a volatile
anaesthetic, administration of halothane and maintenance of
anaesthesia are easily achieved.
Anaesthesia was induced with halothane (Fluothane
ICI) delivered in oxygen from a temperature and oxygen flow-
rate compensated vapouriser (Fluotec Mk 3, Cyprane Limited).
A tracheostomy was then performed and a tracheal cannula
inserted. Animals respired spontaneously throughout the
experiment.
The cannula used consisted of a Pyrex glass tip,
shaped to fit easily into the trachea, to which two Portex
tubes were attached via a Y piece. The oxygen/halothane
mixture was introduced into one Portex tube and flowed out
of the other. The flow rate used was 500 ml/muu During
early experiments, ma ny animals were lost due to the can¬
nula orifice becoming blocked with dried blood and mucus.
This was overcome by regularly siliconising (Repelcote,
Hopkins & Williams Ltd) the cannula.
During the course of the surgery, the halothane con¬
centration was reduced so that, when all the surgery had
been completed, the halothane concentration was 0.5-1%;
it was maintained at this level throughout the experiment.
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2:2.2 PHYSIOLOGICAL MONITORING
Several physiological parameters were continuously
monitored during the course of an experiment.
2:2.2.1. Rectal temperature
The rectal temperature was measured on a thermo¬
meter or via a thermosensitive rectal probe connected
to a galvanometer (Ellab Ltd). The rectal temperature
was maintained between 37° and 38°C throughout the experi¬
ment by a heating pad which was placed under the belly
of the animal. The heating pad was controlled by a
thermosensitive probe which was placed between the pad
and the animal.
2:2.2.2. Electrocardiogram
The electrocardiogram (BCG) was continuously moni¬
tored throughout the experiment. A stainless steel elec¬
trode was inserted beneath the skin of the animals' fore-
limbs* The electrodes used were hypodermic needles,
(19G1 gauge, Gillette). The electrodes were connected
via a wide band AC preamplifier (Grass 7P 3A) to a
driver amplifier (Grass 7DA). Both the preamplifier and
the animal were earthed, providing the third pole necessary
for ECG recording. The ECG was written on paper using
a Grass model 7 polygraph.
2:2.2.3. Electrocorticoqram
The electrocorticogram (ECoG) was continuously
monitored from the side of the brain contralateral'to that
used for recording action potentials. Two small holes
were made in the skull using a dental burr (Ash, round
1 size).
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A silver ball electrode was then carefully placed
on the surface of the dura in each hole and cemented in
place using dental acrylic (Simplex, Dental Fillings Ltd).
The electrodes were connected via a wide baud AC EEG pre¬
amplifier (Grass 7P5A) to a driver amplifier (Grass 7DA)
and the ECoG written out by one pen of a Grass model 7
polygraph.
2:2.3 PREPARATION OF RECORDING SITE
The animal's head was held in a stereotaxic frame
and the skull exposed. An area of the brain was exposed
for the recording of action potentials according to the
method described by Bradshaw and Szabadi (1972).
2:2.3.1. Cerebral Cortex
In order to expose an area of the cerebral cortex
for recording, a small hole was drilled in the skull using
a small dental burr (Ash, Round 1 size). An incision was
then made in the dura under microscopic control. A
micropipette could then be introduced through the incision
and into the brain tissue under microscopic control.
2:2.3.2. Caudate nucleus
An area of the cerebral cortex was exposed as des¬
cribed above. The stereotaxic coordinates chosen for
this exposure were A 8.0; L 2.4 (Konig & Klippel, 1963).
At these coordinates the caudate nucleus lies 2.5 - 3.00 mm
below the surface of the brain (Konig & Klippel, 1963).
Thus, under microscopic control a micropipette could be
lowered through the cortex to the top of the caudate
nucleus.
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In practice, then, studies could be performed in
both the cerebral cortex and caudate nucleus using the
same micropipette and the same micropipette track.
2:2"4 LOCATION OF SPONTANEOUSLY ACTIVE NEURONES
The method of preparing the recording site described
above provided a stable recording situation free from res¬
piratory and circulatory pulsations. To maintain this
stability, micropipettes were advanced through the tissue
slowly. To achieve a slow but steady progress through
the tissue, the micropipette was advanced by means of a
microdrive (La Precision Cinematographique) driven by a
3V DC motor; the motor could be controlled either manually,
or by an automatic device specially built for this purpose
(see paragraph below).
This micropipette advancing device was actually
based on the circuit employed in the sequential timing
device used to control the electrophoretic currents
(2:3.2.2). Two timers were employed which operated alter¬
natively in a continuous cycle. The time period for the
first timer was fixed at 250 msec, whilst the second timer
was variable from 4 to 15 seconds. The microdrive motor
was dris/en during the period of operation of the first
timer by a variable current so that the micropipette could
be advanced in steps of 2 - 20 jam. Thus, the device
could advance the micropipette through the tissue in steps
varying from 8 yum/min to 300 ^um/min. The device could
be instantly stopped once the micropipette was in the
vicinity of a spontaneously active neurone.
Spontaneously active sir.glo neuronea selected for study
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were described as thope with a stable baseline firing
rate, and whose spikes were of unchanging amplitude above
300 ^uV„ Using the techniques described above, such
neurones could be routinely studied for periods of up to
5 hours.
2:2.5 HISTOLOGY
Histological examination was performed on rat brains
which had been used for studies in the caudate nucleus.
First, the multibarrelled micropipette was removed
from the brain. This allowed the track left by the micro¬
pipette to fill with blood which facilitated subsequent
detection^ The animal was sacrificed by an intraperitoneal
injection of a lethal dose of pentobarbitone sodium
(NembutoJL, Abbott Laboratories), the brain quickly removed
and immersed in a solution of 10% formaldehyde in 0„9%
NaCl. After fixation (7 - 14 days) the hind-brain was
removed and the fore-brain mounted on a microtome. The
tissue was frozen using carbon dioxide gas (Distillers Co)
and 20 ^tm sections cut. For staining, the sections were
mounted on glass microscope slides which had been coated
with gelatine (2.5% gelatine with 1% phenol in distilled
water). Slides were stored under formalin vapour until
staining could begin.
The slides were first washed in distilled water
before being immersed in the staining solution for 15 min
at room temperature. The staining solution was a 1%
aqueous solution of Toluidin Blue (Gurr). After staining,
the slides were rinsed in distilled water followed by
rinsing in 95% alcohol. The slides were then immersed in
FIG. 2. Photograph of a transverse section of the rat brain.
CX : Cerebral cortex; NC : Nucleus caudatus putamen.
Approximate Stereotaxic coordinate A8.0 (Konig & Klippel, 1963).
The arrow in the left hemisphere indicates the lesion made by the
micropipette. See text (2:2.5) for details of histological
preparation.
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absolute alcohol (for differentiation) followed by xylene.
Finally, each section was covered by a drop of Depex
mounting material (Gurr) and a cover-slip positioned.
The correct location of the micropipette track could be
verified, using a 10X magnifying glass, by reference to
the atlas (Konig & Klippel, 1963).
Figure 2 shows an example of a section of rat brain
stained using this technique.
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2:3 RECORDING AND DRUG APPLICATION
Conventional techniques were used to record extra¬
cellular action potentials and to apply drugs into the
local environment of a single spontaneously active
neurone. A schematic diagram of the circuits is shown
in Figure 3.
2:3.1 RECORDING OF ACTION POTENTIALS
Extracellular action potentials were recorded
through one barrel of the multibarrelled micropipette as
described by Roberts and Straughan (1967).
The animal was electrically earthed via the stereo¬
taxic frame. The recording barrel of the micropipette
contained 4p1 NaCl, was connected to a capacitance
neutralising electrometer (Bioelectric NF-1, gain 2X).
The output of the electrometer was fed to a preamplifier
(Tektronix FM122, frequency range 0.08 - 10 kHz, gain
10QX), and then to a cathod ray oscilloscope (Tektronix
565, final gain 200X). This signal could also be re¬
corded on magnetic tape for later analysis (Ferrograph
Series Seven). Z-axis modulation was used to intensify
the fast transients on the oocilloscope screen (Pokrovsky,
1960).
Action potentials of equal amplitude were separated
from the electrical noise, and from action potentials of
lower amplitude by an electronic gating device. The out¬
put from the gate was simultaneously displayed on the
oscilloscope screen above the original signal so that the
action potentials passing through the gate were easily
distinguishable. Three methods of recording the digital




output of the gate were used.
First, the signal was fed to a special counter
(Venner Electronics, type 029/X1) which displayed the
total number of action potentials counted in a given
epoch. This information could be printed on to paper
tape (Kienzle printer).
Second, the signal was fed to a unit integrator
(Grass, UI-1) which integrated the number of action
potentials passing through the gate. The output of the
integrator was fed to a driver amplifier (Grass model 7DA).
Thus the integrated signal was described by the pen-
writing oscillopraph (Grass model 7). The system was
calibrated so that the integrator reset to zero when the
oscillograph pen reached full-scale deflection. The re¬
sulting trace is shown in Figure 4. Thus, each excursion
of the pen corresponded to the number of action potentials
produced in a given time.
Third, the signal was fed to a rate-meter (Ecko,
model N 522 C). The output of the rate-meter, the number
of action potentials produced per unit time (the firing
rate of the neurone), was fed via a low-level DC preamp¬
lifier (Grass 7P1A) to a driver amplifier (Grass model 7DA).
Thus the firing rate was written by a pen-writing oscillo¬
graph. The integrator and rate-meter traces were written
out simultaneously one above the other for easy comparison






















FIG. 4. Parameters of an excitatory response of a single
cortical neurone to acetylcholine.
(A) Electrophoretic current passed through the solution of
acetylcholine chloride contained in one barrel of the micropipette
(ordinate: current intensity (nA); abscissa: time (minutes).
(b) Ratemeter recording of the firing rate (ordinate: firing rate
(spikes/s); abscissa: time (minutes)).
(C) Cumulative record of the total number of action potentials
generated by the neurone (ordinate: total spikes; abscissa:
time (minutes)).
Response parameters (see 2:4.1) are indicated by the letters above
and to the right of the traces.
(After Bradshaw et al, 1975c).
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2s3*2 APPLICATION OF DRUGS
All drugs were applied as ions from aqueous solu¬
tions by microelectrophoresis.
The drug solutions used in the experiments were:
1. Dopamine hydrochloride (0.1 or 0.2M, pH 4.0-4.5;
Koch-Light).
2. (-)-noradrenaline bitartrate (0.1 or 0.2M, pH 3.0-
3.5; Koch-Light).
3. 5-hydroxytryptamine bimaleate (0.1 or 0.2M,
pH 3.5; Koch-Light).
4. Mescaline hydrochloride (O.05M, pH 3.5-4.5; Sigma).
5. Acetylcholine chloride (0.1 or 0.2M, pH 3.6;
Koch-Light).
6. Sodium (-)-glutamate (0.05M, pH adjusted to 8.5
by the addition cf C.IN NaOH; British Drug Houses).
7. Desipramine hydrochloride (0.15M, pH 4.5; Geigy).
8. Iprindole hydrochloride (0.05M, pH 4.5; John Wyeth
and Brother).
2:3.2.1. Electrophoretic Current Source
Drug ejecting and drug retaining currents (see
2:3.2.3 below) were provided by the circuit described in
Figure 5. A 300V DC supply was reduced stepwise to ob¬
tain voltages, and thus currents, of an appropriate
magnitude. The final output resistance of the circuit
was 1000 megohmn which effectively minimised any changes
in the current flow due to changes in the electrical re¬
sistance of the drug barrels (Roberts & Straughan, 1967).
The current flow to each barrel of the micropipette could
be measured on a Pye Scalamp galvanometer. Artefacts,
FIG. 5♦ Circuit diagram of the electrophoretic current source
employed in these experiments.
See text (2:3.2.1) for explanation.
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produced by switching from positive to negative current,
for example, were minimised by the use of mercury-wetted
reed switches. These were controlled by an independent
12V circuit. The reed switches could be operated manu¬
ally (switch Sm in Figure 7) or automatically by a sequen¬
tial timing device (Bevan & Bradshaw, 1973). The current
source provided for up to 5 independent electrophoresis
channels.
2:3.2.2. Sequential timers
In the drug interaction studies described below
the change in the size of a neuronal response to an
agonist was followed in time. It was important to en¬
sure that the observed change in the isize of a response
was not due to any physical factors, but was an effect of a
drug interaction. Physical factors which can alters the
size of a response include the parameters of drug ejec¬
tion and retention (Bradshaw, Roberts & Szabadi, 1973b).
Thus, during a drug interaction study, the ejection and re¬
tention times, as well as the ejection and retention cur¬
rents, must be kept constant.
A sequential timing device was built which ensured
that the ejecting and retaining currents were applied to
the drug barrels in a regular sequence during a study so
that each ejection period resulted in a standard amount
of drug released from the barrel (Bradshaw, Szabadi &
Roberts, 1973c).
The sequential timing device consisted of eight
individual timers, and the circuit is shown in Figure 6.
The timers were linked in pairs to form four timer
FIG. 6. Circuit diagram of the sequential timing device used in
these experiments. The start unit (used to initiate the timing




units (1, 11, 111 & IV). Of each unit, one timer con¬
trolled the ejection period (E timer) and the other the
retention period (R timer), independent of the polarity
of the current required for drug ejection (see 2:3.2.3).
The timers operated sequentially (E followed by R; unit 1
followed by unit 11), and cyclically (unit IV followed by
unit 1). The cycle could include one or all of the timers
so that a sequence of up to eight independent times could
be established and repeated indefinitely. The circuit
enabled the programmed application of ejection and retain¬
ing currents from up to 4 electrophoresis channels in a
regular cycle.
The timers were driven by a 12V DC supply and
operated the mercury-wetted reed switches in the electro-
phoretic current source (see 2:3.2.1). More than one
electrophoresis channel could be operated simultaneously
by each unit so that current balancing (2:3.2,4) could
be achieved throughout the experiment.
The programme was initiated by means of the switch
Sa (Figure 7). The inclusion of each channel into the
programme was determined by the switches Sb. Each chan¬
nel could be operated by any, or all, of the timer units
as determined by the switches Sc. If any channel was
not controlled by a particular timer unit, the retaining
current was automatically maintained while that timer unit
was in operation. The direction of the current during
the ejection period was controlled by the switches Sd.
FIG. 7. Schematic diagram of the circuits used in these
experiments to programme the sequential application of
electrophoretic voltages to the micropipette barrels. See







2:3.2.3. Ejecting and Retaining Currents
Drug ions were ejected from barrels of micro-
pipettes by a current passing through the drug solution
in the barrel. Both positive and negative currents could
be passed through each barrel of the micropipette. The
animal was at ground (zero) potential (see 2:3.1). Thus
positive current flowed through the barrel when the animal
was the cathode, whereas, negative current flowed when the
animal was the anode. The polarity of the current used
to eject the drug ion depended on the charge of the drug
ions, in solution. Thus, glutamate, which is negatively
charged at pH 8.5, was ejected from the micropipette by
a negative current. All other drugs used were expelled
from the micropipette as positive ions by a positive cur¬
rent passing through the appropriate barrel. In between
drug applications a retaining current flowed through the
drug solutions to prevent the diffusion of drug ions from
the barrels. The retaining current for each drug was
opposite in polarity to the current which ejected the drugs
from the micropipette (i.e. positive current for glutamate,
negative for all other drugs).
2:3.2.4. Current Balancing
To oontrol for possible current effects, current
balancing (Roberts & Straughan, 1967) was routinely used.
The object of the current balancing procedure was to
maintain a current flow through the micropipette as a whole
which did not change in magnitude or polarity during drug
ejection or retention periods. This was achieved by
currents of appropriate polarity flowing through a 4M NaCl
containing barrel of the micropipette (not the recording
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barrel) so that the total positive and negative currents
passed remained constant during the ejection and retention
periods. For example, if a current of + 50 nA passed
through a barrel to eject a drug, whereas a current of
- 25 nA retained that drug in the barrel, then, during
drug ejection periods a current of - 25 nA passed through
the NaCl containing barrel, whereas, during drug retention
periods, a current of + 50 nA passed through the NaCl
containing barrel. Thus, although the direction and
magnitude of the current flow changed in the drug barrel
during drug ejection, the net change in the micropipette
as a whole was always zero.
Drug ejection involved, then, the simultaneous
changing of the polarity and magnitude of the current
flow in two barrels of the micropipette. This could
be achieved by using the sequential timing device des¬
cribed above (2:3.2.2).
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2:4 ANALYSIS OF RESPONSES
In these experiments, action potentials generated
by a single neurone were defined as spikes of equal ampli¬
tude which were clearly separated from the electrical
noise level and from spikes of lower amplitude.
Pharmacological responseo were evaluated on the basis of
the rate-meter and integrator (see 2:3.1) records.
2:4.1 RESPONSE PARAMETERS
The following parameters describe the response of
a single neurone to a microelectrophoretically applied
drug (see Figure 4, and Bradshaw et al, 1973c):
(a) The spontaneous (baseline) firing rate (Fl)
(b) The response latency (latency of onset of the
response, measured from the onset of the
ejecting pulse) (Tl)
(c) The maximum firing rate (the maximum firing
rate achieved by the cell during the response)
(F2-F1)
(d) The time taken to achieve the maximum firing
rate (T2)
(e) The recovery time (the time taken for the
recovery of the spontaneous firing rate
after the termination of the ejecting pulse)
(T4-T3)
(f) The total spike number.
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2:4.2 CALCULATION OF TOTAL SPIKE NUMBER
The total spike number is a parameter which esti¬
mates the overall size of a response, and was thus used
to assess the degrees of antagonism and potentiation in
drug interaction studies (see 2:5). It was calculated
by taking the difference between the number of action
potentials produced during the response and subtracting
the number of action potentials produced during an equiva¬
lent period when no drug was applied (see Bevan et al,
Thus, in the case of excitatory responses,
the total spike number is the number of action potentials
generated in response to the drug application, whereas,
in the case of depressant responses, it is the number of
action potentials whose generation was suppressed by the
drug application.
Three methods of calculating the total spike
number were developed.
2:4.2.1. Integration
This method required continuous on-line monitoring
of the number of action potentials produced by the
neurone. Impulses from an electronic gating device
(see 2:3.1) were integrated and the output described by
a pen-writing oscillograph (see 2:3,1). The total dis¬
tance moved by the pen was proportional to the number of
action potentials passing through the gate. The integ¬
rator was reset to zero at the beginning of every drug
ejection period, whereas, the end of the response could
be detected by a change in the slope of the integrator
pen write-out (see Figure 4). Thus, comparison of the
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number of excursions of the integrator pen before and
during a response enabled the total spike number to be
calculated.
2:4.2.2. Estimation
Another way to calculate the total spike number
was to measure the area described by the response curve;
that is, the area between the limits F2 and Fl, and T1
to T4 in Figure 4. This area is directly proportional
to the total spike number. Two methods of estimating
the area of the response were used.
2:4.2.2.1. Tracing
The outline of each individual response was copied
on to tracing paper and cut out. The size of each res¬
ponse was thus expressed as the weight of the response
cut-out.
2:4.2.2.2. Planimetry
The area of the respons e was measured direct from
the rate-meter record. A compensating polar planimeter
(A. Ott, model 30.000.113) was used for this purpose.
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2:5 DRUG INTERACTION EXPERIMENTS
The technique of microelectrophoresis was used to
assess the interaction between tricyclic antidepressant
drugs and putative neurotransmitters.
2:5.1 METHOD OF STUDY
The agonist (a putative neurotransmitter) was
applied in a regular cycle. The intervals between
agonist applications, and the durations of agonist appli¬
cations, were kept constant using a sequential timing
device (see 2:3.2.2). Similarly, during a study, the
ejecting and retaining currents were kept constant. This
ensured that the standard ejecting current pulses gave
rise to standard pulses of agonist ejection (Bradshaw
et al, 1973c). ' Several, control responses were obtained
before a drug-interaction study. The size of a response
was expressed as the total s®&ke number. Cells we re
excluded from drug-interaction studies if the variation
in the size of the responses to the agonist exceeded ^ 10%
(see Bradshaw et al, 1974).
2:5.2 APPLICATION OF ANTIDEPRESSANTS
The tricyclic antidepressants were applied either
continuously or in the form of a brief pulse.
2:5.2.1. Continuous Application
First, control responses to an agonist were ob¬
tained, as described above (2:5.1). Then, the antidep¬
ressant was ejected from the micropipette continuously,
using low ejection currents (0-15 nA). The application
of the antidepressant was continued even during the agonist
applications. With this method the concentration of the
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antidepressant would rise gradually to a plateau, and this
concentration would then be maintained for the rest of the
antidepressant application , (Szabadi & Bradshaw, 1974). Once
the application had ceased, the concentration would then
gradually decline to zero.
This method was only successful on one occasion
(see Figure 27). Almost invariably, during the appli¬
cation of the antidepressant, the spike height would be
drastically reduced so that the study had to be abandoned.
Usually, after terminating the antidepressant application,
the spike height would recover. This effect probably
reflects the local anaesthetic action of these drugs
(Domenjoz & Theobald, 1959). This method was discontinued
in favour of pulse application.
2:5.2.2. Pulse Application
First, control responses to an agonist were ob¬
tained, as described above (2:5.1). Then, the antidep¬
ressant was ejected from the micropipette as a brief pulse,
the current through the antidepressant barrel being 30 -
100 nA passed for 30 - 80 seconds. This procedure did not
interrupt the regular sequence of agonist application.
The difficulties associated with the continuous
application of antidepressants were overcome using this
technique. However, the higher currents which were used
with pulse application revealed an agonistic action of the
antidepressants (see Results). Little evidence of the
local anaesthetic action was observed with this technique.
Cells showing a reduction in spike height due to the appli¬




In any drug interaction regime it is necessary to
establish the degree of specificity of the observed effects.
This was accomplished in the experiments reported here by
the use of a control agonist. Originally, in the study of
the effects of tricyclic antidepressants on neuronal res¬
ponses to monoamines, ACh was used as a control agonist.
However, these experiments showed that responses of single
neurones to ACh were affected in a similar manner to res¬
ponses to the monoamines (Bradshaw et al, 1971a; Sevan et
al; 1973c; 1975a), Therefore, in the experiments re¬
ported here, glutamate was used as the control agonist.
Responses of single neurones to glutopiate are not affected
by tricyclic antidepressants (Bradshaw et al, 1974;
Bevan et al, 1975a).
Ideally, the effect of the antidepressant should be
studied on the test agonist and control agonist at the same
time. However, the experiments reported here involved
following the iime-course of the changes in the size of the
response to the agonist after the application of a brief
pulse of the tricyclic antidepressant drug. This dictated
that only one agonist could be tested at a time, as the
inclusion of another (control) agonist into the sequence
would necessarily increase the time between the applications
of the test agonist. This usually prohibited the simul¬
taneous examina tion of the effects of antidepressants on
the responses to the control and test a.gonists, However,
the interaction between antidepressants and the control
and test agonists could still be tested on the same cell.
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Once a successful drug interaction study had been comp¬
leted with a test agonist, the study could be repeated
on the same cell with the control agonist, using the same
dose of tricyclic antidepressant drug.
2:5.4 DEFINITION OF EFFECTS
In the drug interaction studies described below,
three possible effects could be observed.
2:5.4.1. Potentiation
A response was regarded as potentiated if there was
an increase of at least 20% in the size of the response
when compared to the size of the mean of the control res¬
ponses, as determined by the total spike number (see 2:4.2).
2:5.4.2. Antagonism
A response was regarded as antagonised if ther e was
a decrease of at least 20% in the size of the response when
compared to the size of the mean of the control responses,
as determined by the total spike number (see 2:4.2).
2:5.4.3. Reversal
Following the application of an antidepressant, the
direction of a response (excitation or depression) was re¬
versed, later to recover. For example, the cell first
responded with a clear excitation to the agonist; following
the application of the antidepressant, however, the same
agonist evoked an opposite response (depression). Later,
the original excitatory response to the agonist recovered.
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BIOCHEMICAL EXPERIMENTS
2 :6 MATER IALS
2:6,1 INCUBATION MEDIA
2:6,1.1. Mammalian Ringer
Mammalian Ringer solution was prepared fresh daily
by the addition of the appropriate volume of distilled
water to a preweighed mixture of salts. The final con¬
centration (meq/1) of each ion species was as follows
(Burgen.& Mitchell, 1968):
Na+, 159.9; K+, 5.6; Ca++, 4.4; Cl", 163.9; HC03~, 5.9;
Glucose, 5.0. The pH of this solution was 7.4.
2:6.1.2. Sodium-free Ringer
Sodium-free Ringer solution was prepared according
to two methods described by Horn (1974). With the first
method, each sodium salt was replaced with the appropriate
choline salt. Thus the ionic composition of the medium
remained unchanged, except that choline ions had been sub¬
stituted for sodium ions. With the second method, all
sodium salts were simply omitted. This inevitably meant
MM +
that the concentration of Cl and HCO^ , as well as Na ,
was changed. The final concentration (meq/1) of each
-J- +
ion species was thus as follows: Na , 0; K , 5.6;
Ca++, 4.4; Cl~, 5.6; ^^3 » 0; Glucose, 5.0. To obtain
an isotonic incubation medium using this latter method, the
salts were dissolved in 0.32 M sucrose solution instead of
distilled water (Horn, 1974).
The pH of sodium-free incubation medium was 7.4.
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2:6.2 SCINTILLATION FLUID
The scintillation fluid contained 0.267% PPO
(2,5-diphenoxyloxazole), 0.0067% POPOP (1,2,bis-.
(5-phenyloxazole)-benzene) in toluene with 33% Triton
X-100. All reagents used were scintillator grade
(British Drug Houses Limited).
2:6.3 RADIOACTIVE COMPOUNDS
The radioactive drug solutions used in the
experiments were:
14
1. Noradrenaline. (-)-noradrenaline-carbinol C-
bitartrate, specific activity 5.0 mC/mmole;
Radiochemical Centre Limited.
14
2. Mescaline. Mescaline-8- C-hydrochloride,




Synaptosomes were isolated and incubated according
to a modification of the method described by Maxwell et al,
(1974).
2:7.1 PREPARATION OF SYNAPTOSOMES
The procedure for the preparation of synaptosomes
is outlined in Figure 8.
For each experiment, one male albino Wistar rat,
weighing between 250 and 250 g was sacrificed by decapi¬
tation. The brain was quickly removed and the cerebral
cortex dissected from the rest of the tissue on ice.
The cerebral cortex Wa-Si; immediately homogenised in
0.32 M sucrose (10 ml) using a teflon pestle and glass
vessel. The blood and cellular debris were separated
by centrifugation at 1000 g for 10 min at 4°C. The
supernatent was removed and centrifuged at 17000 g for
5 min at 4°C. A pellet was formed which was considered
to be rich in synaptosomes (see Gray & Whit taker, 1961).
This pellet was resuspended in cold mammalian Ringer
solution (70 ml).
2:7.2 INCUBATIONS
An example of an experimental protocol is shown in
Figure 9*
Synaptosome-rich Ringer solution (4.9 ml) (see
2:8.1) was added to each incubation flask. A 0.9% solu¬
tion of NaCl (0.05 ml) was added to control flasks while
a solution of the test substance (0.05 ml) was added to
the test flasks. The flasks were pie-incubated at 37°C














































after which a solution of C-labelled monoamine (0.05 ml)
was added to each flask « The incubations were then con¬
tinued for a further 10 minutes.
The temperature and sodium dependent nature of the
monoamine uptake were assessed by variations of the above
experimental protocol. In order to determine the
temperature-dependent nature of uptake, the pre-incubation
and incubation temperatures were changed to 4°C (see, for
example, Maxwell et al, 1974). The sodium dependency
was investigated by performing the incubations in sodium-
free Ringer solution (see 2:6.1.2).
Incubations were stopped by pouring the contents
of each flask into chilled tubes, followed by the immediate
centrifugation at 15000 g for 5 min at 4°C. The resulting
(synaptosome-rich) pellet was washed in 0.9% NaCl (5 ml)
and the centrifugation repeated. The supernatent from
the wash was discarded and the pellet blotted dry.
2:7.3 ASSAY PROCEDURES
Standard biochemical techniques were employed for
the estimation of radioactivity and protein concentration
in each incubation sample.
14
2:7.3.1. Estimation of C-monoamlne content
The washed pellet (2:7.2) was homogenised in 0.4 N
perchloric acid (1 ml) and the homogenate allowed to stand
for 30 minutes. The protein thus precipitated was removed
by centrifugation at 15000 g for 5 min at 4°C. An aliquot
of the supernatant (0.5 ml) was added to a glass scintil¬
lation vial, containing IN NaOH (0.2 ml) to neutralise the
acid, and scintillation fluid added (10 ml). Radioactivity
ISOTOPE 14C-mescaline SPECIFIC ACTIVITY 5.2 mCi/mmole
INHIBITOR De sipramine (DMI)
PRE-INCUBATION: 5 MINS
INCUBATION: 10 MINS @ 37 ' °n
NO. ISOTOPE CONCN ^uM): CONTROL TEST
1 1 .000 0.9# NaCl 0.05/uM DM1
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FIGURE 9 Example of a biochemical experimental protocol
6 incubation flasks were prepared in duplicate.
"Control" flasks contained 0.9# NaCl (0,05 ral) whereas "Test"
flasks contained O.C5yuM desipramine (0.05 ral). To each
flask was aided synaptusome-rich Ringer solution and the radio¬
active monoamine solution (see 2:7*2).
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was measured in a Packard liquid scintillation spectro¬
meter, where counting efficiency was monitored by the
channel ratio method (Red channel: gain 8%,
discriminator 50 - 125V; Green channel: gain 8%,
discriminator 50 - 1000 V).
2:7.3.2„ Estimation of Protein Content
The precipitated protein (2:7.3.1) was dissolved
by heating for 30 min in 2N NaOH (5 ml) at 100°C. The
protein content of this solution was estimated according
to the method described by Lowry, Rosebrough, Farr and
Randall (1951). Bovine serum albumin was used to con¬
struct standard curves for this estimation.
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2:8 ESTIMATION OF THE PARAMETERS OF MONOAMINE UPTAKE
KINETICS
2:8.1 DEFINITIONS
Monoamine "uptake" is defined as the effect of a
process whereby a monoamine is accumulated into synapto-
somes. The uptake velocity is the number of moles of
monoamine accumulated by each incubation sample (2:7.3.1)
corrected for the protein concentration (2:7.3.2) and for
the time of incubation. Thus the uptake velocity is ex¬
pressed as pmoles/min/mg protein.
The terms Vm and Km are defined on the basis of
enzyme kinetics. Vm is the maximum uptake velocity of
the system being studied, whereas Km is the monoamine
concentration which gives rise to the half-maximal
uptalce velocity (Mahler & Cordes, 1966).
2:8.2 CALCULATION OF Vm AND Km
For both monoamines examined, the uptake velocity
was determined for different concentrations of the mono¬
amine in the incubation medium. The data were analysed
using regression analysis. In the case of data which demon¬
strated Michaelis-Menten type kinetics, the analyses were
performed using the method described by Wilkinson (1961).
This method provides accurate estimates for the Vm and Km.
In the case of experiments performed in the presence of an
inhibitor, the method provides estimates for the apparent
Vm and apparent Km.
Thus, by s tatistically comparing the Vm and Km
with the apparent Vm and apparent Km (see below), the effect
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of the inhibitor was established. The nature of the
inhibition was defined on the basis of enzyme kinetics
(see Results) (Mahler & Cordes, 1966).
2:8.3 STATISTICAL TESTS
For both monoamines examined, an estimate of Km
and Vm was calculated according to the method of
Wilkinson (1961). Using this method, the standard error
of the estimate was also calculated for Km and Vm„
The statistical significance of the difference
between two estimates was evaluated using Student's
t-test. Levels of probability were estimated from the
two-tailed Student's t-distribution.
Two estimates were considered as differing signi¬
ficantly if the probability of the difference occurring




3:1 RESPONSES OF SINGLE NEURONES TO PUTATIVE
NEUR OTRANSMITTERS
3:1.1 INTRODUCTION
The postulated transmitter role of the monoamines,
and their implication in the action of psychotropic drugs,
forms the background to the many investigations into the
sensitivity of central neurones to NA, DA and 5HT. Both
excitatory and inhibitory responses of single cortical
neurones to NA and 5HT (Bradshaw et al, 1971a; 1973a;
1974; Bevan et al, 1974a) and to DA (Stone, 1974) have been
reported. Similarly, both excitatory and depressant res¬
ponses to NA and DA have been reported in the caudate
nucleus (Spencer & Havlicek, 1974). However, there is
considerable disagreement between different research groups
concerning the true nature of the response to each mono¬
amine. Depressant responses have been attributed to the
use of barbiturate anaesthesia (Johnson et al, 1969b). It
has been suggested that excitatory responses are artefacts
produced by the expulsion of hydrogen ions from acidic drug
solutions (Jordan et al, 1972a). Excitatory responses have
also been attributed to an anoxia produced by the vaso¬
constrictor action of monoamines on blood vessels adjacent
to the site of recording (Stone, 1972).
As a preface, then, to the description of the drug-
interaction studies, a survey of the effects of putative
neurotransmitters on single neurones in the cerebral cortex
and caudate nucleus of the rat is reported.
TABLE
Responsesofc rticalneuronestmono minesa dac ty choline Response(numberofcells)
Agonist Dopamine Noradrenaline 5-hydroxytryptauine Acety1choline
Excitation 20(5 %) 23(47%) 8(57%) 22(100%)
Depression 17(43%) 20(41%) 5(36%) 0(0%)
Biphasic 3(7%) 6(12%) 1(7%) 0(0%)
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3:1o 2 RESPONSES OF SINGLE NEURONES IN THE CEREBRAL
CORTEX TO THE MONOAMINES AND ACETYLCHOLINE
The effects of DA, NA, 5HT and ACh were studied on
125 spontaneously active neurones in the cerebral cortex.
Three types of responses could be observed: 1. excitation;
2. depression; and 3. biphasic responses, consisting of an
initial depressant phase followed by an excitatory phase.
Table 1 shows the frequency of occurrence of these effects.
In order to determine whether an agonist had pro¬
duced predominantly excitatory or depressant effects, the
numbers of exci.tations and depressions observed in response
to each agonist were examined using the "Binomial, test.
(Biphasic responses were not considered in this analysis.)
The Null hypothesis was that the probability of observing
an excitatory response is 0.5. For both NA and DA, the
Null hypothesis was upheld: there was an equal probability
of observing either excitatory or depressant responses.
In the case of 5HT and of ACh, there was a significantly
greater probability of observing excitatory responses than
of observing depressant responses (p = 0.005 and 0.002 for
5HT and ACh respectively).
3:1.3 RESPONSES OF SINGLE NEURONES IN THE CAUDATE
NUCLEUS TO THE MONOAMINES AND ACETYLCHOLINE
The effects of DA, NA, 5HT and ACh were studied on
208 spontaneously active neurones in the caudate nucleus.
As in the cerebral cortex, three types of responses to each
agonist could be observed: 1. excitation; 2. depression;
and 3. biphasic responses. Figure 10 shows an example of
each type of response to the microelectrophoretic •'
FIG. 10. Examples of the types of response to dopamine (DA)
observed in these experiments. Each excerpt is taken from rate
meter recordings of the firing rate of a single neurone in the
caudate nucleus. Ordinates: firing rate (spikes/s);
abscissae: time (minutes). Horizontal bars indicate DA
applications; numbers refer to intensity of ejecting current
(nA).
(A) Excitatory response. (b) Biphasic response (depressant
phase followed by excitatory phase). (C) Depressant response.
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application ox DA; Table 2 shows the frequency of occur¬
rence of each type of response for all four agonists.
In order to determine whether an agonist had pro¬
duced predominantly excitatory or depressant effects, the
numbers of excitations and depressions observed in response
to each agonist were examined using the Binomial test
(see 3:1.2). Biphasic responses were not considered in
this analysis. The Null hypothesis was that the probabi¬
lity of observing an excitatory response is 0.5. In the
case of DA and NA, there were no significant differences
(p >0.05).between the numbers of excitations and depressions
actually observed and the numbers predicted by the Null
hypothesis. However, there was a significant increase in
the number of excitatory responses to 5HT (p = 0.005) and
ACh (p = 0.002) compared with the numbers predicted by the
Null hypothesis.
On eight cells a "spontaneous reversal" of the res¬
ponse to the monoamine could be observed: the cell first
responded with a clear depression or excitation to the
monoamine; later, however, the same monoamine evoked an
opposite response. "Spontaneous response reversal" was
observed on four cells with DA, two cells with NA and on
two cells with 5HT. An example of spontaneous reversal is
shown in Figure 11. This cell was initially depressed by
the application of NA (50nA for 60 sec). However, the
subsequent application of NA evoked an excitatory response.
Cells showing "spontaneous response rever sal'1 wer e not used
for drug interaction studies.
TABL5
Responsesofcaudateneuron stinon aminesa dacetylrho11 Response(numberofceils)
Agonist Dopamine Noradrenaline 5-hydroxytryptamine Acetylcholine
Excitation 33^53%) 32(50%) 32(64%) 52(91%)
Depression 21(34%) 26(41%) 12(24%) 4(7%)
Biphasic 8(13%) 6(9%) 6(12%) (2%)
FIG. 11. Spontaneous response reversal. Ratemeter recording
of the firing rate of a single neurone in the caudate nucleus.
Ordinate: firing rate (spikes/s); abscissa: time (minutes).
Horizontal bars indicate noradrenaline (na) applications;
numbers refer to the intensity of the ejecting current *
(a) Depressant responses to na. (b) Subsequential appli¬















3:1.3.1. Correlation between responses to dopamine
and responses to other agonists
On 48 cells in the caudate nucleus responses to DA
and to another agonist (NA, 5HT, ACh) were compared. (On
a number of cells, responses to DA and to two other agonists
were tested.) Table 3 shows the correlation between the
direction of the response (excitation or depression) to DA
and the direction of the response to the other aopnist.
It is apparent that there was a highly significant corre¬
lation between the effects of DA and NA, whereas there was
no significant correlation between the effects of DA and
5HT. Furthermore, there was no significant correlation
2
between responses to DA and Ach (\ test).
3:1.4 DISCUSSION
Other authors have described the occurrence of
excitatory and depressant responses to DA (Gonzalez-Vegas,
1974; Siggins et al, 1974; Spencer & Havlicek, 1974) and
to NA (Spencer & Havlicek, 1974) in the caudate nucleus of
the rat. Similarly, both excitatory and depressant res¬
ponses to NA, DA and 5HT (Stone, 1973a;: 1973b) and to.DA
(Stone, 1974) have been described in the cerebral cortex of
the rat. Furthermore, both excitatory and depressant res¬
ponses to NA, DA and 5HT have been described in the cerebral
cortex and caudate nucleus of the cat (see Curtis & Crawford,
1968).
In the experiments described above both excitatory
and depressant responses to NA, DA and 5HT were observed in
the cerebral cortex and caudate nucleus of the rat. With
the exception of 5HT, there was no significant difference
TABLE3
Correlatenbetweenthffectsofdop minedfotherago istsoaudateeuron s * Agonistscompared Dopamine,N radrenalin(33) Dopamine,5-hydroxytryptamine(19) Dopamine,Acetylcholin(17)Directionofresp nsest thetwoagonists Same 91% 79% 71%
Qpposite 9% 21% 29%
Signifinance ofcorrelation (X2test) p<0.001 N.S. N.S.
*
Figuresinparenthesisindicatenumb rofllsnwhichcompa isonswered .
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between the number of excitatory ana of depressant responses
to a monoamine; there was an equal probability of observing
excitatory and depressant responses to both NA and DA. In
the case of 5HT, however, excitatory responses predominated
in both the cerebral cortex and caudate nucleus.
Some neurones responded in a biphasic fashion to the
monoamines (see Tables 1 and 2). Biphasic responses to
the monoamines have been reported in the cerebral cortex of
the cat (Johnson et al, 1969a; Szabadi & Bradshaw, 1974)
and in the caudate nucleus of both the rat (York, 1970) and
the monkey (York, 1972). The presence of biphasic res¬
ponses, and the observation of spontaneous response rever¬
sal, may suggest that both excitatory and inhibitory recep¬
tors to the same monoamine can co-exist on the same cell
(Szabadi & Bradshaw, 1974).
In the caudate nucleus, there was a high correlation
between both excitatory and depressant effects of DA and
NA, whereas there was no significant correlation between
the effects of DA and 5HT (see Table 3). This suggests
that DA and NA may act at similar receptors on caudate
neurones. Indeed, it is known that DA can stimulate
cx -receptors in the periphery (Rossum, 1965).
Both excitatory and inhibitory responses to ACh have
been reported in the cerebral cortex (Stone, 1973) and
caudate nucleus (Spencer & Havlicek, 1974) of the rat, and
similar results have been reported in the cerebral cortex
(Crawford & Curtis, 1966) and caudate nucleus (McLennan &
York, 1966) of the cat. However, in the experiments des¬
cribed above, ACh evoked exclusively excitatory responses
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in the cerebral cortex, and almost invariably evoked
excitatory responses when applied to single neurones in the
caudate nucleus.
When, in the caudate nucleus, responses to DA and
ACh were compared on the same neurone, no significant cor¬
relation could be found between the directions of the res¬
ponses to the two agonists (see Table 3). This would
argue against the claim that DA and ACh have opposite
effects in the caudate nucleus (Klawans, 1968; Yahr &
Duvoisin, 1972).
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.3:2 THE EFFECTS OF DESIPRAMINE ON RESPONSES OF
SINGLE CAUDATE NEURONES TO MONOAMINES AND ACETYLCHOLINE
3:2.1 INTRODUCTION
It is generally believed that the symptomatology of
Parkinson's disease is caused by the selective degeneration
of the dopamine-containing nigrostriatal pathway which
leads to an impaired balance between dopaminergic and
cholinergic inputs in the striate nucleus (Barbeau, 1962;
Klawans, 1968). Drugs effective in the treatment of
Parkinson's disease are thought to act either by inhibiting
the effects of acetylcholine (eg. atropine), or by enhancing
the effects of dopamine (eg. L-DOPA) (Klawans, 1968;
Yahr & Duvoisin, 1972).
It has been reported that desipramine, a tricyclic
antidepressaint drug, is effective in the treatment of
Parkinsonism (Laitenen, 1969). The basis for the anti¬
parkinsonian efficacy of desipramine, however, is not
known. Although the anticholinergic effects of desipramine
are well documented (Atkinson & Ladinsky, 1972) it is not
likely that this is the sole explanation for the anti¬
parkinsonian efficacy of the drug, since the therapeutic
effectiveness of desipramine is greatly enhainced by the
concurrent administration of another anticholinergic (Yahr
& Duvoisin, 1972). Another possibility could be that
desipramine potentiates the effects of dopamine (DA) in the
caudate nucleus. Such an effect, however, could not be
predicted on the basis of the well known 'uptake blockade
hypothesis of potentiation * (Iversen, 1974), since desip¬
ramine is almost completely ineffective in blocking the
FIG. 12. Effect of desipramine and iprindole on the firing
rate of single neurones. The figure shows excerpts from the
ratemeter recording of the firing rate of 4 single, neurones
Ordinatesj firing rate (spikes/s); abscissae: time (minutes).
Each excerpt is from a different neurone. Horizontal bars
indicate applications of a tricyclic antidepressant drug.
(A) Depressant (left) and excitatory (right) effect of desip¬
ramine (DMl) on the firing rates of single caudate neurones.
(b) Depressant (left) and excitatory (right) effect of iprindole





















uptake of NA in the caudate nucleus (Ross & Renyi, 1967;
Horn et al, 1971).
It has been reported that desipramine has a dual
effect on neuronal responses to noradrenaline (NA), 5-
hydroxytryptamine (5HT) and acetylcholine (ACh) in the
cerebral cortex: both antagonism and potentiation of the
responses can be observed (Bradshaw et al, 1971a; 1974;
Bevan et al, 1973c; 1975a). In the experiments reported
here, the technique of microelectrophoresis was used in
order to examine how, in the caudate nucleus of the rat,
neuronal responses to DA, NA, 5HT and ACh could be affected
by desipramine.
3:2.2 EFFECT OF DESIPRAMINE ON NEURONAL FIRING
The direct effect of desipramine on the firing rate
was studied on 65 cells. The dose cf antidepressant
applied was 30 - 100 nA passed for 30 - 80 seconds. On
6 cells (9%) the firing rate was increased during the
application of desipramine, whereas on 19 cells (20%) the
firing rate was decreased. There was no significant corre¬
lation between the dose of desipramine applied and the
effect on neuronal firing. An example of both the excita¬
tory and depressant effects of desipramine on the firing
rate is shown in Figure 12A. On occasions a reduction in
spike amplitude was observed; such cells were not used for
drug interaction studies.
FIG. 15. Potentiation of excitatory responses of a single
caudate neurone to dopamine (DA) by desipramine (PMl). Top
of the figure shows excerpts from the ratemeter recording of
the firing rate of the neurone. Horizontal bars indicate
applications of DA; numbers refer to the intensity of the
ejecting current (nA). (a) Control response to DA.
(B) Potentiated response to DA one minute after a brief appli¬
cation of DMI (40 nA; 80 seconds). Recovery of control res¬
ponse 25 minutes after the application of DMI. The graph at
the bottom shows the time-course of the entire study. The
sizes of the responses to DA are expressed as a percentage of
the mean of the control responses. Each column represents a
single response. Letters above the graph indicate responses
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FIG. 14. Antagonism and potentiation of excitatory responses
of a single caudate neurone to dopamine (DA) by desipramine (DMI).
Top of the figure shows excerpts from the ratemeter recording of
the firing rate of the neurone (as in Fig. 1j). (A) Control
response to DA. (b) Antagonised response, 8 minutes after a
brief application of DMI (50 nA; 50 seconds). (c) Potentiated
response, 38 minutes after the application of DMI. (D) Recovery
of the control response 58 minutes after the application of DMI.
Graph at the bottom shows the time-course of the entire study
(as in Fig. 13).
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3 ; 2. 3 EFFECT OF PES IFRAMINE ON RESPONSES TO DOPAMINE
3:2.3.1. Excitatory responses
Both potentiation and antagonism of excitatory res¬
ponses to DA could be observed after a brief application
(30 - 100 nA for !30 - 80 seconds) of desipramine.
Potentiation of the response was seen on 5 cells.
An example of potentiation is shown in Figure I3.
Antagonism of the response to DA was seen on -6 cells.
Qs 3 cells, both potentiation and antagonism could be
observed. On each of these cells the response was first
antagonised following the application of desipramine; this
antagonism was followed later by potentiation and finally
by recovery of the control response. An example of this
dual effect of desipramine on excitatory responses to DA
is shown in Figure 14. On 2- - cells, no significant
change in the size of the response could be observed after
the application of desipramine. The degrees of potentiation
and antagonism observed on each cell are summarised in
Figure 20.
Ln another 3.; cells, the excitatory response to
DA was reversed into a depressant response following the
application of desipramine.
3:2.3.2. Depressant responses
Both potentiation and antagonism of depressant res¬
ponses to DA could be observed after a brief application of
desipramine. Potentiation was seen on 6 . cells, anta¬
gonism was seen on 3 cells. On one cell both antagonism
and potentiation could be observed. An example of the
potentiation of the depressant response to DA by desipramine
FIG, 15. Potentiation of depressant responses of a single
caudate neurone to dopamine (DA) by desipramine (DMI). Top of
the figure shows excerpts from the ratemeter recording of the
firing rate of the neurone (as in Fig. 13). (A) Control response
to DA. (B) Potentiated response to DA 13 minutes after a brief
application of DMI (100 nA; 50 seconds). (c) Recovery of the
control response 21 minutes after the application of DMI. Graph
at the bottom shows the time-course of the entire study (as in
Fig. 13).
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is shown in Figure 15. On one cell no significant change
in the size of the response could be observed after the
application of desipramine. The degrees of potentiation
or antagonism seen on each cell are summarised in Figure 20.
On 6 other cells, the depressant response to dopa¬
mine was reversed into an excitation following the appli¬
cation of desipramine.
3:2.4 EFFECT OF DESIPRAMINE ON RESPONSES TO NORADRENALINE
3:2.4.1. Excitatory responses
Both potentiation and antagonism of excitatory res¬
ponses to NA could be observed after a brief application of
desipramine. Potentiation was observed on 4 cells,
antagonism was seen on 6 cells. On one cell both anta¬
gonism and potentiation could be observed, the antagonism
preceding the potentiation,. An example of the potentiat¬
ing effect of desipramine on responses to NA is shown in
Figure 16. On one cell no significant change in the size
of responses could be observed after the application of
desipramine. The degrees of potentiation or antagonism
seen in each cell are summarised in Figure 20.
On one further cell the excitatory response to NA
was reversed into a depression following the application of
desipramine.
3:2.4.2c Depressant responses
Potentiation was seen on 6 cells depressed by NA,
antagonism was observed on 4 cells. Both effects could
be seen on 2 cells. On 2 cells no effect of desipramine
could be observed. Figure 20 summarises the degrees of
FIG. 16. Potentiation of excitatory responses of a single
caudate neurone to noradrenaline (HA) by desipramine (DMi).
Top of the figure shows excerpts from the ratemeter recording of
the firing rate of the neurone (as in Fig.13). (a) Control
response to NA. (b) Potentiated response to HA 6 minutes after
a brief application of DMI (100 nA; 60 seconds). (c) Recovery
of the •ontrol response 31 minutes after the application of DMI.

































FIG. 17. Drug induced response reversal. Excerpts from the
ratemeter recording of the firing rate of a single caudate neurone.
Ordinate! firing rate (spikes/s); abscissae: time (minutes).
Horioontal bars indicate the application of noradrenaline (NA);
numbers refer to the intensity of the ejecting current (nA).
(A) Control response (depression) to NA.
(B) The response to NA was reversed into an excitation 45 minutes
after the application of desipramine (50 nA; 50 seconds).
(c) Recovery of the depressant response to NA 160 minutes after
the application of desipramine.
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potentiation or antagonism observed on each cell.
On another 4 cells the depressant response to
noradrenaline was reversed into an excitatory one following
the application of desipramine. An example of a depressant
response which was reversed following the application of
desipramine is shown in Figure 17.
3:2.5 EFFECT OF DESIHRAMINB ON RESPONSES TO
5-HYDRQXYTRYPTAMINE
3:2.5.1. Excitatory responses
Both potentiation and antagonism of excitatory res¬
ponses to 5HT could be observed after a brief application
of desipramine.
Potentiation of the response was observed on 4
cells. Antagonism of the response was seen on 3 cells.
On 2 cells both antagonism and potentiation of the res¬
ponse could be seen; the antagonism preceded the potentia¬
tion. An example of the dual effect of desipramine on
excitatory responses to 5HT is shown in Figure 18. On 2
cells no effect of desipramine could be observed. The data
are summarised in Figure 20.
3:2.5.2. Depressant responses
On one cell, the depressant response to 5HT was re¬
versed into an excitation, following the application of
desipramine.
3:2.6 EFFECT OF PESIPRAMINE ON RESPONSES TO
ACETYLCHOLINE
Both potentiation and antagonism of excitatory res¬
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FIG. 18. Antagonism and potentiation of excitatory responses of a
single caudate neurone to 5-hydroxytryptamine (5HT) by desipramine
(DMl). Top of the figure shows excerpts from the ratemeter
recording of the firing rate of the neurone (as in Fig. 13)»
(A) Control responses to 5HT. (b) Antagonised response, 58
minutes after a brief application of DMI (50 nAj 60 seconds),
(c) Potentiated response, 78 minutes after the application of DMI.
(D) Recovery of the control response 116 minutes after the appli¬
cation of iprindole. Graph at the bottom shows the time-course of
the entire study(as in Fig. 15)-
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of desipramine.
Potentiation was observed on 4 cells, antagonism
was seen on " 4 cells. On one cell both antagonism and
potentiation could be seen; the antagonism preceded the
potentiation. An example of the potentiating effect of
desipramine on responses to ACh is shown in Figure 19. On
2 cells desipramine had no significant effect. The data
are summarised in Figure 20.
3:2.7 EFFECT OF DESIPRAMINE ON RESPONSES TO GLUTAMATE
The effect of desipramine on excitatory responses to
glutamate was studied on 10 cells. The effects of gluta-
mate on the firing rate were studied for 20 - 30 minutes
following the application of desipramine. On none of the
cells could any significant change be observed in the size
of the responses to glutamate after the application of
desipramine (see Figure 20). An example of a study of the
effect of desipramine on responses of a single caudate
neurone to glutamate is shown in Figure 21.
3:2.8 DISCUSSION
Desipramine applied by microelectrophoresis had a
dual effect on responses to monoamines and ACh: both
antagonism and potentiation of the responses could be ob¬
served. Responses to glutamate were not affected. A
dual effect of desipramine on responses to NA and 5HT
(Bradshaw et al, 1971a; 1974) and on responses to ACh
(Bevan et al, 1973c; 1975a) has been described in the
cerebral cortex of the cat.
FIG. 19. Potentiation of excitatory responses of a single
caudate neurone to acetylcholine (ACh) by desipramine (DMl).
Top of the figure shows excerpts from the ratemeter recording of
the firing rate of the neurone (as in Fig. 13). (a) Control
response to ACh. (b) Potentiated response to ACh 4 minutes
after a brief application of DMI (50 nA; 40 seconds),
(c) Recovery of the control response 26 minutes after the appli¬
cation of DMI. Graph at the bottom shows the tine-course of the

























































The antagonism of responses to NA could be inter¬
preted on the basis of the <x-adrenoceptor blocking effect
of desipramine (Turker & Khairallah, 1967). Since receptors
to NA and DA are likely to be very similar on caudate
neurones, an <y-receptor blocking action could explain the
antagonism of responses to DA. The antagonism of responses
to 5HT may be explained on the basis of the anti-serotonin
action of the antidepressants (Domenjoz & Theobald, 1959),
whereas the antagonism of responses to ACh may reflect the
antimuscarinic action of these drugs (Atkinson & Ladinsky,
1972).
It is more difficult to interpret the potentiating
effects of desipramine. In the case of 5HT, the most
plausible explanation is uptake blockade. There is indirect
evidence that 5HT terminals reach the caudate nucleus
(Gumulka, Ramirez del Angel, Samanin & Valzelli, 1970), and
that desipramine inhibits the uptake of 5HT into brain
tissue (Ross & Renyi, 1969). Uptake blockade, however,
cannot explain the potentiation of responses to DA and NA
by desipramine. It is known that both DA and NA are
accumulated by an active uptake process in the striatum
(Horn et al, 1971); this uptake, however, is almost
entirely unaffected by desipramine (Ross & Renyi, 1967;
Horn et al, 1971).
The results presented here show that desipramine can
potentiate neuronal responses to DA in the caudate nucleus.
It is possible that this action is responsible for the
therapeutic efficacy of desipramine in Parkinson's disease.
However, responses to ACh can also be potentiated by
FIG. 20. Summary of the effects of desipramine on neuronal
responses to dopamine, noradrenaline, 5-hydroxytryptamine (5HT),
acetylcholine (ACh) and glutamate (GLU).
A. Potentiations each point shows the maximum potentiation
observed on one individaul cell (e.g. response B in Fig. 13).
+: excitatory responses; —s depressant responses. A response
was regarded as potentiated if there was more than 20% increase
over the size of the control response (see2:5.4)«
B. Antagonism: each point shows the maximum degree of antagonism
observed on one individual cell (e.g. response B in Fig. 14). 4
response was regarded as antagonised if there was more than 20%











































FIG. 21. Effect of desipramine (DMl) on responses of a single
caudate neurone to glutamate. Excerpt* from the ratemeter
recording of the firing rate of the neurone. Ordinates: firing
rate (spikes/s); absciassae: time (minutes). Solid bars under¬
neath the abscissae indicate the applications of glutamate (50 nA).
Open bars underneath the abscissae indicate the applications of
desipramine. Desipramine, when ejected with current of 50 nA















desipramine, and this might counteract the anti-Parkinsonian
effect of desipramine. This may explain why a small dose
of a potent anticholinergic drug has to be administered con¬
currently with desipramine in order to obtain the full
therapeutic benefit from the antidepressant in Parkinsonism
(Yahr & Duvoisin, 1972).
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3:3 THE EFFECTS OF IPRINDOLE ON RESPONSES OF SINGLE
CORTICAL AND CAUDATE NEURONES TO MONOAMINES AND
ACETYLCHOLINE
3:3.1 INTRODUCTION
Iprindole is a tricyclic antidepressant drug with a
similar structure and clinical antidepressant efficacy to
imipramine (Imlah, Murphy & Mellor, 1968; Rickels, Chung,
Csanalosi, Sablosky & Simon, 1973). Similarly to imipra-
mine, iprindole potentiates the peripheral effects of NA
(Gluckman & Baum, 1969). However, in contrast to imipramine
and other tricyclic ant idepre ssan t compounds, iprindole does
not block the uptake of NA into sympathetically innervated
tissues (Gluckman & Baum, 1969; Lahti & Maickel, 1971).
It has also been reported that, in contrast to imipramine
and desipramine, iprindole is ineffective in blocking the
uptake of NA (Ross et al, 1971; Rosloff & Davis, 1974),
dopamine (DA), and 5HT (Ross et al, 1971) into brain tissue.
It is not known, however, how pharmacological responses to
the monoamines are affected by iprindole in the brain. In
the experiments reported below, the technique of microelec¬
trophoresis was used in order to investigate how responses
of single cortical and caudate neurones to NA, DA, 5HT and
ACh could be modified by iprindole.
CEREBRAL CORTEX
3:3.2 EFFECT OF IPRINDOLE ON NEURONAL FIRING
The effect of iprindole on the firing rate was
studied on 68 cells. The dose of antidepressant applied
was 30 - 100 nA applied for 30 - 60 seconds. On 4 cells
FIG. 22. Potentiation of excitatory responses of a single
cortical neurone to noradrenaline (NA) by iprindole. Top of the
figure shows excerpts from the ratemeter recording of the firing
rate of the neurone (as in Fig. 13). (A) Control response to NA.
(B) Potentiated response to NA 21 minutes after a brief application
of iprindole (50 nA; 30 seconds). (c) Recovery of control
response 37 minutes after the application of iprindole. The
graph at the bottom shows the time-course of the entire study






































(6%) the firing rate was increased during the application of
iprindole, whereas on 19 cells (28%) the firing rate was
decreased. There was no significant correlation between
the dose of iprindole applied and the effect on neuronal
firing. An example of both the excitatory and depressant
effects of iprindole on the firing rate is shown in
Figure 128. On occasions, a reduction in spike amplitude
was observed; such cells were not used for drug interaction
studies.
3:3.3 EFFECT OF IPRINDOLE ON RESPONSES TO NORADRENALINE
3:3.3.1. Excitatory responses
Both potentiation and antagonism of the responses to
NA could be observed after a brief application (30 - 100 nA
for 30 - 60 seconds) of iprindole.
Potentiation was seen on 6 cells. An example of
potentiation is shown in Figure 21. On one cell, the res¬
ponse was first reduced in size following the application of
iprindole; this antagonism was followed later by poten¬
tiation, and finally by recovery of the control response.
On 2 cells no significant change in the size of the res¬
ponse could be observed after the application of iprindole.
The degrees of potentiation and antagonism observed on each
cell are summarised in Figure 28.
3:3.3.2. Depressant responses
Both potentiation and antagonism of the depressant
responses could be observed sifter a brief application of
iprindole.
Potentiation was seen on 10 cells, antagonism was
seen on 3 cells. On 2 cells both antagonism and
FIG. 23. Potentiation of depressant responses of a single
cortical neurone to noradrenaline (NA) by iprindole. Top of the
figure shows excerpts from the ratemeter recording of the firing
rate of the neurone (as in Fig. 13). (A) Control response to NA.
(B) Potentiated response one minute after a Brief application of
iprindole (100 nAj 60 seconds). (c) Recovery of the control
response 11 minutes after the application of iprindole Graph at





potentiation could be observed; in ooth cases antagonism
preceded potentiation. An example of the potentiation of
the depressant response to NA by iprindole is shown in
Figure 23.
On one cell no significant change in the size of
response could be observed after the application of
iprindole. The degrees of potentiation and antagonism
seen in each cell are summarised in Figure 28.
3:3.4 EFFECT OF IPRINDOLE ON RESPONSES TO DOPAMINE
3:3.4.1. Excitatory responses
Both potentiation and antagonism of excitatory res¬
ponses to DA could be observed after a brief application of
iprindole.
Potentiation of the responses was seen on 5 cells,
antagonism was seen on 4 cells. On 3 cells both
antagonism and potentiation of the response could be ob¬
served; antagonism always preceded potentiation. Figure
24 shows an example of potentiation, and Figure 25 shows
an example of antagonism followed by potentiation. On one
cell no significant change in the size of responses could
be observed after the application of iprindole. The degrees
of potentiation or antagonism seen in each cell are sum¬
marised in Figure 28.
3:3.4.2. Depressant responses
Potentiation was seen on 3 cells depressed by
DA, antagonism was seen on one cell. Figure 28 summarises
the degrees of potentiation or antagonism observed in each
cell.
FIG, 24. Potentiation of excitatory responses of a single
cortical neurone to dopamine (DA) by iprindole. Top of the figure
shows excerpts from the ratemeter recording of the firing rate of
the neurone (as in Fig. 13)« (A) Control response to DA.
(B) Potentiated response to DA 17 minutes after a Brief appli¬
cation of iprindole (100 nA; 60 seconds). (c) Recovery of the
control response 31 minutes after the application of iprindole.
Graph at the Bottom shows the time-course of the entire study
(as in Fig. 1 3)•
 
FIG. 25. Antagonism and potentiation of excitatory responses of
a single cortical neurone to dopamine (da) by iprindole. Top of
the figure shows excerpts from the ratemeter recording of the
firing rate of the neurone (as in Fig. 13). (a) Control response
to da. (b) Antagonised response, 1 minute agter a brief appli¬
cation of iprindole (50 nAj 50 seconds). (c) Potentiated res¬
ponse, 55 minutes after the application of iprindole.
(d) Recovery of the control response 71 minutes after the appli¬
cation of iprindole. Graph at the bottom shows the time-course




3:3.5 EFFECT OF IFRINDOLB ON RESPOTnoES TO
ACETYLCHOLINE
Both potentiation and antagonism of excitatory res¬
ponses to ACh could be observed after a brief application
of iprindole. Potentiation of the response was seen on
3 cells, Antagonism was seen on . 5 cells* On 3
cells, both antagonism and potentiation could be observed;
antagonism always preceded potentiation. An example of
antagonism followed by potentiation is shown in Figure 26.
On 2 cells iprindole had no significant effect on the size
of the responses to ACh. The data are summarised in
Figure 28.
On one cell, the effect of the continuous application
of iprindole was examined (Figure 37). Iprindole, when
applied with a current of 5 nA, potentiated the response to
ACh. When the current used to apply iprindole was inc¬
reased to 10 nA, the size of the response to ACh was
attenuated back to its control level. When an even larger
current was used to apply iprindole (15 nA), the response to
ACh was antagonised. After the application of iprindole
had been terminated, the response recovered from the anta¬
gonism; this was followed by the potentiation of the res¬
ponse and finally by recovery of the control response.
3:3.6 EFFECT OF IPRINDOLE ON RESPONSES TO GLUTAMATE
The effect of iprindole on excitatory responses to
glutamate was studied on 10 cells. The effects of gluta-
mate on the firing rate were studied for 20 - 30 minutes
following the application of iprindole. On none of these
FIG. 26. Antagonism and, potentiation of excitatory responses of
a single cortical neurone to acetylcholine (ACh) by iprindole.
Top of the figure shows excerpts from the ratemeter recording of
the firing rate of the neurone (as in Fig. 13). (A) Control
response to ACh. (b) Antagonised response, 6 minutes after a
brief application of iprindole (50 nA; 50 seconds),
(c) Potentiated response, 52 minutes after the application of
iprindole. (d) Recovery of the control response 75 minutes after
the application of iprindole. Graph at the bottom shows the time-
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FIG. 27. Antagonism and potentiation of excitatory responses of a
single cortical neurone to acetylcholine (ACh) by iprindole (IER).
Top of the figure shows excerpts from the ratemeter recording of
the firing rate of the neurone (as in Fig. 13). (a) Control res¬
ponse to ACh. (b) Response to ACh was potentiated during the
application of iprindole (5 nA). (c) Response to ACh was
attenuated back to the control size during the application of ip¬
rindole (10 nA). (D) Response to ACh was antagonised in the
presence of iprindole (15 nA). (E) Response to ACh was poten¬
tiated 74 minutes after the application of iprindole had been
terminated. (f) Recovery of response to ACh 115 minutes after
the application of iprindole had been terminated. The graph at
the bottom shows the time-course of the entire study (as in Fig. 13)
The horizontal bars under the abscissa refer to the intensity of
the current used" to apply iprindole .
FIG. 28. Summary of the effects of iprindole on responses of
single cortical neurones to dopamine, noradrenaline, acetylcholine
(ACh) and glutamate (GLU).
A. Potentiation: each point shows the maximum potentiation
observed on one individual cell (e.g. response B in Fig. 21).
+: excitatory responses; -: depressant responses. A response
was regarded as potentiated if there was more then 20°/o increase
over the size of the control response (see 2:5.4).
B. Antagonisms each point shows the maximum degree of antagonism
observed on one individual cell (e.g. response B in Fig. 24).
A response was regarded as antagonised if there was more than 20^o



















































cells could any significant change be observed in the size
of the responses to glutamate after the application of
iprindole (see Figure 28). An example of a study of the
effect of iprindole on responses of a single cortical
neurone to glur&mate is shown in Figure 29.
CAUDATE NUCLEUS
3:3.7 THE EFFECTS OF IPRINDOLE ON RESPONSES TO
NORADRENALINE, DOPAMINE AND 5-HYDRQXYTRYPTAMINE
The direct effect of iprindole on re uronal firing in
the caudate nucleus was studied on 18 cells: 3 cells were
excited, 2 cells were depressed, whereas on 13 cells there
was no change in the firing rate. The effect of iprindole
was also examined on neuronal responses to NA, DA and 5HT.
The same patterns of drug interaction could be observed as
described above. Following a brief application of iprin¬
dole, both antagonism and potentiation of excitatory res¬
ponses to NA (2 cells), DA (3 cells) and 5HT (3 cells)
could be observed. Similarly, both antagonism and poteni-
tiation of depressant responses to NA (3 cells) and DA (5
cells) was seen. Excitatory responses to glutamate (3
cells) were not affected by iprindole. Figure 30 shows the
dual effect of iprindole on excitatory responses to 5HT, and
Figure 31 shows an example of the potentiation of depressant
responses to DA by iprindole.
3:3.8 DISCUSSION
A brief application of iprindole did not affect the
firing rate of the majority of neurones tested in the cortex
and in the caudate nucleus. On a small number of cells,
FIG, 29. Effect of iprindole (iHl) on responses of a single
cortical neurone to glutamate. Excerpti from the ratemeter
recording of the firing rate of the neurone. Ordinates: firing
rate (spikes/s); abscissae: time (minutes). Solid bars under¬
neath the abscissae indicate the applications of glutamate (50 nA)$
the open bar indicates the application of iprindole (50 nA).




however, a response to iprindole was observed. A possible
explanation for this effect of iprindole itself could be
that it reflects the interaction between engogenously
released monoamine transmitters and iprindole. As res¬
ponses to ACh are also affected by iprindole, an interaction
with ACh released by cholinergic inputs to the neurone should
also be considered. Similarly to iprindole, imipramine and
desipramine can also evoke excitatory and depressant res¬
ponses on spontaneously firing cortical neurones (Bradshaw
et al, 1974). On a few cells, a reduction in spike ampli¬
tude was observed in response to iprindole. This probably
..." ■ • . •>' • ; • V- • . * :: ! : . i . " • M t
reflects the local anaesthetic action of tricyclic antidep¬
ressant drugs (Domenjoz & Theobald, 1959).
Iprindole has a dual effect on responses of cortical
and caudate neurones to monoamines (NA and DA in the cereb¬
ral cortex, NA, and DA and 5HT in the caudate nucleus).
Both antagonism and potentiation of the response to a mono¬
amine could be observed after a brief application of
iprindole. When both antagonism and potentiation of the
response occurred after a single application of iprindole,
antagonism invariably preceded the development of poten¬
tiation (see Figure 25). As after a brief ejecting pulse,
the concentration of iprindole probably rises quickly to a
peak, and then gradually declines (Bradshaw et al, 1974),
antagonism of the responses to the monoamine is likely to
reflect a higher, whereas potentiation a lower concentration
of the antidepressant (see Bradshaw et al, 1974).
FIG. 50 Antagonism and, potentiation of excitatory responses
a single caudate neurone to 5-hydroxytryptamine (5HT) by iprin
Top of the figure shews excerpts from the ratemeter recording
the firing rate of the neurone (as in Fig. 15). (a) Control
response to 5HT. (B) Antagonised response, 3 minutes after
brief application of iprindole (100 nA; 50 seconds).
(C) Potentiated response, 12 minutes after the application of
iprindole. (D) Recovery of the control response 32 minutes
after the application of iprindole. Graph at the bottom show




The most plausible explanation for antagonism is the
blockade of monoamine receptors on the post-synaptic neurone,
This would indicate that iprindole probably shares the
adrenoceptor blocking and ant iserotonin actions of other tri¬
cyclic antidepressants (Domenjoz & Theobald, 1959;
Callingham, 1967).
As iprindole is ineffective in blocking the uptake oi
NA, DA and 5HT into the brain tissue (Ross et al , 1971),
uptake blockade cannot be an explanation for the poten¬
tiation observed in these experiments. An alternative
explanation for potentiation will be discussed in Chapter 4.
Iprindole has a dual effect not only on responses to
monoamines, but also on responses to ACh: both antagonism
and potentiation can be observed. It is likely that the
antagonism reflects a higher, whereas potentiation a lower
concentration of iprindole (see Figure 27, and Bevan et al ,
1975a). This could explain the results obtained from the
study in which iprindole was applied continuously (see Figure
27). When iprindole was ejected continuously from the micro-
pipette by a low current (5 nA) , the excitatory response to
ACh was potentiated. When a larger current (15 nA) was used
to apply iprindole, the response to ACh was amtagonised.
After the application of iprindole had been terminated, the
concentration of iprindole probably declined slowly (see
above) so that potentiation of the response to ACh gradually
developed, to be followed later by recovery of the control
response. As in the case of imipramine, desipramine and
atropine (Bevan et al, lt<75a), the antagonism can be inter¬
preted by a blockade of muscarinic receptors, since it has
been reported that iprindole blocks the effects of ACh in
peripheral test systems (Gluckman & Baum, 1969). The
FIG. 51 . Potentiation of depressant responses of a single
caudate neurone to dopamine (DA) by iprindole. Top of the f:
shows excerpts from the ratemeter recording of the firing rate
the neurone (as in Fig. 13). (A) Control response to DA.
(B) Potentiated response to DA 12 minutes after a brief appl:
cation of iprindole (100 nA; 50 seconds). (C) Recovery of
control response 27 minutes after the application of iprindole
Graph at the bottom shows the time-course of the entire study
(as in Fig. 13).
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potentiation of neuronal responses to ACh by iprindole may
be due to the selective blockade of masked inhibitory recep¬
tors (see Bevan et al, 1975a and Chapter 4),
- 94 -
3:4 THE EFFECT OF DESIPRAMINE ON RESPONSES OF SINGLE
CORTICAL NEURONES TO MESCALINE
3:4.1 INTRODUCTION
The uptake blockade hypothesis of potentiation sug¬
gests that the potentiation of monoamine responses by tri¬
cyclic antidepressant drugs is a consequence of the ability
of such drugs to inhibit the accumulation of monoamines into
nerve terminals. Iversen (1967) has shown that mescaline
(3,4,5-trimethoxyphenylethylafnine) has .a very low affinity
for catecholamine uptake mechanisms in the periphery. It
was therefore of great interest to determine whether
neuronal responses to mescaline could be potentiated by tri¬
cyclic antidepressant drugs, since it is unlikely that such
an effect would be mediated by an effect on the uptake of
mescaline.
When applied to single cortical neurones, mescaline,
like NA and 5HT, evoked both excitatory and depressant res¬
ponses (Bradshaw et al, 1971b; Bevan et al, 1974a; 1974b).
It has also been shown that responses to NA, 5HT and mesca¬
line can be antagonised by methysergide and sotalol, while
responses to ACh are not affected (Bevan et al, 1974a;
1974b). In the present study, the effect of desipramine
on responses of single cortical neurones to mescaline was
investigated.
3:4.2 EFFECT OF PESIFRAMINE ON RESPONSES TO MESCALINE
Both potentiation and antagonism of excitatory res¬
ponses to mescaline could be observed after a brief appli¬
cation (30 - 100 nA for 30 - 60 seconds) of desipramine.
FIG. 32. Potentiation of excitatory responses of a single
cortical neurone to mescaline f Mlflsc) by deeipraaine (PMl).
Top of the figure shows excerpts from the ratemeter recording of
the firing rate of the neurone (as in Fig. 15). (a) Control
response to mescaline. (B) Potentiated response to mescaline
one minute after a brief application of DMI (50 nA; 40 seconds),
(c) Recovery of control response 17 minutes after the application
of desipramine. The graph at the bottom shows the time-course
of the entire study (as in Fig. 13)«
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Potentiation of th& response was seen on 10 cells.
An example of potentiation is shown in Figure 32. Antago¬
nism of the response to mescaline was seen on 5 cells. .
On 5 .cells, both potentiation and antagonism could be
observed; antagonism always preceded potentiation. On 2
cells, no significant change in the size of the response to
mescaline could be observed after the application of
desipramine.
3:4.3 EFFECT OF DESIPRAMINE ON RESPONSES TO GLUTAMA.TE
The effect of desipr amine on the excitatory responses
to glutamate was studied on 10 cortical neurones. The
effects of glutamate on the firing rate were studied for
20 - 30 minutes following the application of desipr amine.
On none of these cells could any significant change be
observed in the size of the response to glutamate after the
application of desipramine (see Figure 33).
3:4.4 DISCUSSION
The results show that desipramine had a dual effect
on the responses of single cortical neurones to mescaline;
both antagonism and potentiation of the responses could be
observed. Responses to glutamate were not affected by
desipramineo Thus responses to all three monoamines, NA,
5HT and mescaline, are affected in a similar way by
desipramine.
As receptors to mescaline, NA and 5HT are likely to
be very similar on cortical neurones (Bevan et al, 1974a),
the antagonism of responses to mescaline could be interpreted
on the basis of the cx.-adrenoceptor blocking effect of desip¬
ramine (Turker & Khairallah, 1967), or alternatively, by the
FIG. 55. Effect of desipramine (DMl) on excitatory responses to
mescaline (:MESC) and to glutamate (GLU) of a single cortical
neurone. Top of the figure shows excerpts from the ratemeter
recording of the firing rate of the neurone (as in Fig. 13)«
(a) Control responses to mescaline and glutamate. (b) Potentia¬
tion of the response to mescaline 14 minutes after the application
of DMI (100 nAf 30 seconds). The response to glutamate was not
affected. (c) Recovery of the control response to mescaline
28 minutes after the application of DMI. The graph at the bottom
shows the time-course of the entire study (as in Fig. 13).
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antiserotonin action of tricyclic antidepressants (Domenjoz
& Theobald, 1969).
The potentiation of responses to mescaline by desip-
ramine is raore difficult to explain. Mescaline is a mono¬
amine which apparently has a very low affinity for uptake
mechanisms in the periphery (Iversen, 1967)„ It would
appear, then, that the uptake blockade hypothesis of poten¬
tiation (Iversen, 1974) cannot explain the potentiation by
desipramine of neuronal responses to mescaline.
3:5 BIOCHEMISTRY
3:5.1 INTRODUCTION
Excitatory responses of single cortical neurones to
mescaline can be potentiated by desipramine (see 3:4). It
has been reported that mescaline has a very low affinity for
catecholamine uptake mechanisms in the periphery (Iversen,
1967), which may imply that mescaline is not actively accumu¬
lated into nervous tissue. On this basis it was considered
unlikely that the potentiation of neuronal responses to
mescaline by desipramine resulted from the inhibition of the
accumulation of mescaline into nerve terminals.
There are no data, however, concerning the uptake of
mescaline into brain tissue. Therefore, the uptake of
14
C-mescaline into synaptosomes prepared from rat brain
14
cerebrffi.,1 cortex was examined. As the kinetics of C-NA
accumulation into synaptosomes are well documented (see
14
Iversen, 1974), the kinetics of C-NA accumulation was also
examined as a control. Finally, the effect of desipramine
14
on the accumulation of C-mescaline was examined and again
parallel experiments with 14C-NA served as controls.
3:5.2 THE UPTAKE OF NORADRENALINE
Table 4 shows, for different NA concentrations in the
incubation medium (the substrate concentrations), the uptake
velocity of NA into synaptosomes incubated at 4°C and 37°C.
It can be seen that, at each NA concentration, the uptake
velocity at 4°C was less than 10% of that at 37°C. Figure
34 shows the data displayed graphically.
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FIG. 34• The uptake of noradrenaline. Plot of the uptake
velocity (V pmole/min/mg protein) against the NA-substrate con¬
centration (SyuM) for two different incubation temperatures.
Each point is the mean (- standard error) of at least 4
determinations. The lines were fitted by regression analysis.
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and 4°C, for each concentration, was taken as the tempera¬
ture dependent uptake velocity (Maxwell et al, 1974).
Fiqure 36 shows for NA (closed circles) the temperature
dependent uptake velocity at different NA concentrations.
The graph on the left (A) is a plot of the uptake velocity
(V) against the NA concentration (S). From this graph, the
maximum uptake velocity (Vm) was calculated to he 19.2 -
0.7 pmoles/min/mg protein, and the NA concentration giving
use to the half-maximal uptake velocity (Km) was calculated
to be 0.63 - 0.05yuM. The graph on the right (Figure 363,
closed circles) shows the data displayed according to the
method of Linexveaver and Burk (1934).
3:5.3 THE UPTAKE OF MESCALINE
As with NA, the uptake of mescaline into synaptosomes
was examined at 37°C and 4°C. The uptake of mescaline into
synaptosomes incubated in a sodium free medium at 37°C was
also examined.
3:5.3.1. Temperature dependency of mescaline uptake
Table 5 shows, for different mescaline concentrations,
(the substrate concentrations), the uptake velocity of mes¬
caline into synaptosomes incubated at 4°C and 37°C in mam¬
malian Ringer solution (see 2:6.1.1). It can be seen that,
at each mescaline concentration, the uptake velocity at 4°C
v^as less than 50% of that at 37°C. Figure 35 shows the data
displayed graphically.
The difference between the uptake velocities at 37°C
and 4°C, for each mescaline concentration, was taken as the
temperature dependent uptake velocity (Maxwell et al, 1974).
Figure 36 shows for mescaline (closed triangles) the tempera¬
ture dependent uptake velocity at different mescaline con¬
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FIG. 35. The uptake of mescaline. Plot of the uptake
velocity (V pmoles/min/mg protein) against the mescaline substrate
concentration (SyuM). Synaptosomes were incubated at 37° C in
the mammalian Ringer solution, 37° C in sodium-free Ringer solution,
or at 4° C in mammalian Ringer solution. Each point represents
the mean (- standard error) of at least 4 determinations. The





the uptake velocity (V) against the mescaline concentrations
(S). From this graph, the maximum uptake velocity (Vm) was
calculated to be 2.63 - 0.87 pmoles/min/mg protein and the
*4*
Km was calculated to be 1.24 - 0.27 ^uM. The graph on the
right (Figure 3^8, closed triangles) shows the data dis¬
played according to the method of Lineweaver and Burk (1923).
3s503.2. Sodium dependency of mescaline uptake
Table 6 compares the uptake velocity of mescaline into
synaptosomes incubated in a sodium-free medium at 37°C
(see 2:6.1.2) with the uptake velocity of mescaline into
synaptosomes incubated in a sodium-containing medium (2:6.1.1)
at both 37°C and 4°C. Removal of sodium ions from the
incubation medium resulted in a 50% drop in the uptake velo¬
city of mescaline at both mescaline concentrations tested,
despite the fact that the incubation temperature was 37°C.
Indeed, the uptake velocity of mescaline at 37°C in sodium-
free conditions did not differ significantly from the uptake
velocity of mescaline at 4°C where the sodium concentration
was physiological. This was true of both mescaline concen¬
trations tested.
3,5-4 THE EFFECT OF PESIPRAMINE ON THE UPTAKE OF NA
The effect of desipramine on the temperature dependent
uptake of NA was examined. The concentration of desipra¬
mine in the incubation medium was 0.05 yuM.
Table 7 shows the effect of desipramine on the uptake
of NA. The data, analysed by Wilkinson's method (see
2:8.2) show that desipramine did not significantly alt«r the
Vm for the uptake; however the apparent Km was significantly
increased with respect to the control.
TABLE6
Theuptakeofmescalineinsodium-freeonditions
Mescalinesubstrate concentrationS(yjM) 0.500 0.066
NormalLinger 0.65-.04 0.06-. 1




isnostatisticaldifference(p>0„02,test)'b tw enhuptakev locityat4°C O"s"(normalRinger)andthuptakeve ocityt37C(Na-freeRing r)f rbo h mescalinesubstrateconce trations.
TABL.57
Effectofdesipramine(DMI)othup akefnoradrenaline(NA)
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FIG. 56. The temperature-dependent uptake of noradrenaline and
mescaline.
(A) Plot of the temperature-dependent uptake velocity
(V pmoles/min/mg protein) against the substrate concentration
(SyuM) for noradrenaline and mescaline-
(B) Lineweaver-Burk plot of 1/V against 1/S for noradrenaline and
mescaline.
Each point represents the mean (- standard error) of at least 4






Figure 37 shews the Lineweaver-Burk plot of the data.
The open circles represent the uptake of NA in the presence
of 0.05^iM dosipramine and the closed circles represent the
controls. Desipramine produced an increase in the slope of
the line with respect to the control. However, the y-
intercept (1/Vm) xvas not significantly altered whereas the
x-intercept (1/Km) was significantly different with respect
to the control. This is consistent with the criteria for
competitive inhibition, and by using the analogy of enzyme
kinetics (sea Mahler & Cordes, 1966), the Ki for desipramine
was calculated to be 0.049 - 0.003 yuM.
3:5.5 THE EFFECT OF DESIPRAMINE ON THE UPTAKE OF MESCALINE
The effect of desipramine on the temperature dependent
uptake of mescaline was studied. The concentration of
desipramine in the incubation medium was 0.05 ^uM.
Table 8 shows the effect of desipramine on the uptake
of mescaline. The data, analysed by Wilkinson's method
(see 2:8.2) show that desipramine did not significantly alter
the Vm or Km for mescaline uptake.
Figure 38 shows the Lineweaver-Burk plot of the data.
The open triangles represent the uptake of mescaline in the
presence of 0.05 uM desipramine and the closed triangles
represent the controls. Compared to the control, desip¬
ramine produced a small, non-significant change in the
slope of the line; neither the y-intercept nor the x-
intercept differed significantly from the controls.
Subsequently, the effect on mescaline uptake of inc¬
reasing concentrations of desipramine was studied (see
Dixon, 1953). The concentration of mescaline in the
TABLE8
Effectofd'esipramine(DMI)othuptakefescaline








































FIG. 37. The effect of desipramine on noradrenaline uptake.
Lineweaver-Burk plots of the reciprocal of the temperature-
dependent uptake velocities of NA (1/v) against the reciprocal of
the NA-substrate concentration (l/s) in the presence and absence
of desipramine. Each point is the mean (- standard error) of at




























FIG. 58. The effect of desipramine on mescaline uptake.
Lineweaver-Burk plots of the reciprocal of the temperatube-
dependent uptake velocities of mescaline (1/v) against the recip¬
rocal of the mescaline substrate concentration (1/s) in the
presence or absence of desipramine. Each point is the mean
(- standard error) of at least 4 determinations. Lines were
fitted by regression analysis*
■■■.»riivinw.«•
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incubation medium was either 0.1 or 1 jiM. Table 9 shows,
for both these concentrations of mescaline, the effect of
increasing the concentration of desipramine on the uptake
velocity of mescaline. There was no significant difference
becween the uptake velocities of mescaline at any desipramine
concentration. Figure 39 is a plot of the reciprocal of
the uptake velocity of mescaline against the desipramine
concentration (see Dixon, 1953). The open circles rep-
recent the uptake velocity for 1 ^aM mescaline, whereas the
closed circles represent the uptake velocity for 0.1 ^uM
mescaline. Linear regression analysis showed the two lines
to be parallel.
Thus, desipramine, within the concentration range
0„C5 to 5 ^uM did not inhibit the temperature dependent
uptake of mescaline.
3:5.6 THE EFFECT OF MESCALINE ON 1HE UPTAKE OF NA
The effect of mescaline on the temperature dependent
14
uptake of G-NA was studied. The concentration of mes¬
caline in the incubation medium was 10 jjM.
Table 10 shows the effect of mescaline on the uptake
of NA. The data, analysed by Wilkinson's method (2:8.2)
shoi»/ that mescaline did not significantly alter the Km of
NA uptake. However, the Vm of NA uptake was significantly
reduced in the presence of mescaline.
Figure 40 shows the Lineweaver-Burk (1923) plot of
the data. The open circles represent the uptate of NA in
the presence of 10 mescaline and the closed circles rep¬
resent the controls. The presence of mescaline increased
the slope of the line with respect to the control. However,
the x-intercept does not significantly differ from the
TABLE9
Effectofdesipramine(DMT)ntheuptakefmescaline
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FIG. 59« The effect of desipramine on mescaline uptake.
Dixon plots of the reciprocal of the temperature-dependent uptake
of mescaline (1/v) against the concentration of desipramine (i) in
the incubation medium. The substrate concentration of mescaline
in the incubation medium was either 0.1 yuM or 1 yuM.
Each point is the mean (- standard error) of at least 4



























control whereas the y-intercept does differ significantly from
the control. This is consistent with the criteria for non¬
competitive inhibition, and using the analogy of enzyme
kinetics (see Mahler & Cordes, 1966), the Ki for mescaline
was calculated to be 10.55 ^ 0.81 yuM.
3:5.7 DISCUSSION
The results show that NA is accumulated into synapto-
somes prepared from the cerebral cortex by a temperature
dependent uptake mechanism; the Km for this uptake mechanism
w0,3 0.62 ^jM„ This is in good agreement with data published
in the literature. For example , Wong, Horng and Fuller
(1973) reported the Km for the active uptake of NA into
synaptosomes to be 0.63^pM. Similarly, Coyle and Snyder
(1959) reported that the Km for NA uptake was 0.4 ^pM.
Desipramine competitively inhibited the uptake of NA
into synaptosomes; the apparent Km was increased whilst the
Vm remained unchanged. In agreement with other authors
(see Iversen, 1974), the Ki for desipramine was found to be
0.049 jjMa Thus NA was accumulated into synaptosomes by an
active, desipramine-sensitive process. This preparation
was used to determine whether mescaline could be accumulated
into synaptosomes.
There have been no studies of the accumulation of
mescaline into synaptosomes in vitro. Denber and Teller
(1967) found that, following the intraperitoneal injection
14
of C-mescaline, radioactivity was found in the brain. A
small proportion of this radioactivity was associated with
nerve-ending particles when the brain was subsequently homo¬
genised (Denber A Teller, 1970). However, because the
TABLE10
Effectofm s alineontheuptakefnoradrenaline(NA)
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FIG, 40. The effect of mescaline on NA uptake
Lineweaver-Burk plots of the reciprocal of the temperature-
dependent uptake of NA (1/v) against the reciprocal of the NA-
substrate concentration (1/S) in the presence or absence of
mescaline. Each point is the mean (- standard error) of at




intraperitoneal route was used, the possibility that the
radioactivity represented metabolites of mescaline could not
be completely excluded (Deuber & Teller, 1967).
The results presented here show that mescaline is
accumulated into synaptosomes, prepared from the cerebral
cortex, by a temperature and sodium dependent process. The
Km for this active process was found to be 1.24 ^iM and the
Vm vas 2,. r 3 pmoles/min/mg protein. The rate of mescaline
uptake is, then, much lower than that of NA (see above;
Km, 0,62 Vm, 19,2 pmoles/min/mg protein).
Desipramine competitively inhibited the uptake of NA.,
but id not affect the uptake of mescaline into rat cerebral
coxtax synaptosernes. There was no change in the Km or Vm
for mescaline uptake when 0.05desipramine was present in
the incubation medium. Indeed, no effect of desipramine on
mescaline uptake could be detected even when desipr amine
concentrations ranging from 0.05 to 5 yoM were present in the
incubation medium.
It would, appear, then, that the NA uptake and mesca¬
line uptake mechanisms could be different. The NA uptake
mechanism is desipramine sensitive whereas the mescaline
uptake mechanism is not. More evidence for a difference
between NA and mescaline uptake processes is provided by the
observation that the inhibition of NA uptake by mescaline was
of a non-competitive nature. If Nfi. and mescaline were
accumulated by the same uptake mechanism, one would expect
mescaline to competitively inhibit the accumulation of NA
(Mahler & Cordes, 1966).
The uptake of mescaline is not blocked by desipramine.
- 104 -
Therefore, vre can conclude that the potentiation by desip-
r&mine of neuronal responses to mescaline (see 3:4) is not




The monoamine theory of affective disorders (see
1:2) suggests that antidepressant drugs could act by
increasing the concentration of monoamine transmitters at
functionally important sites in the brain. It has been
suggested that tricyclic antidepressant drugs may produce
such an effect by inhibiting the uptake of monoamine trans¬
mitters into presynaptic nerve terminals (Iversen, 1974).
The uptake blockade hypothesis of potentiation (Iversen,
1974) thus proposes that this inhibition of monoamine
uptake would be reflected in an enhanced response to mono¬
amines of pharmacological test systems, for example, the
cat nictitating membrane preparation (Sigg, 1959).
Tricyclic antidepressant drugs in fact have two
effects, namely potentiation and antagonism, on monoamine
responses (Callingham, 1967; Bradshaw et al, 1974).
This dual effect has been attributed to two independent
mechanisms. Potentiation has been explained on the basis
of the blockade of monoamine uptake into nerve terminals
(Herrting et al, 1961; Schildkraut, 1965; Iversen, 1974),
whereas the antagonism has been related to <x-receptor
blockade (Turker & Khairallah, 1967). Uptake blockade,
and thus potentiation, usually occurs at lower concen¬
trations, whereas x-receptor blockade, and thus antagonism,
usually occurs at higher concentration of the tricyclic
antidepressant drugs (see below).
There is good evidence for this proposal derived
from experiments in peripheral test systems. In the cat
nictitating membrane, for example, imipramine and desipra-
mine had a dual effect on responses to NA: small doses
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potentiated whereas large doses antagonised the responses
(Sturraan, 1971). Moreover, in a postganglionically
denervated - preparation, that is, a preparation with no
presynaptic terminals, no potentiation of the response
could be observed; antagonism only was seen (Sturman,
1971). Similar results have been obtained using the
rabbit ear artery (Callingham, 1967; McCulloch & Story,
1972) and guinea pig vas deferens (Westfall, 1973)
preparations. Low doses of desipramine potentiated the
contractile responses to NA whereas higher doses antagonised
the responses. Once again, in the denervated prepar¬
ation, only antagonism of the contractile responses could
be observed (Callingham, 1967; McCulloch & Story, 1972;
Westfall, 1973), indicating the importance of presynaptic
terminals for potentiation.
The dual action of tricyclic antidepressant drugs
on neuronal responses to monoamines has also been described
in the central nervous system (Bradshaw et al, 1971a;
1974). Low doses of imipramine or desipramine potentiated
the responses of single cortical neurones to NA and 5HT
whereas higher doses antagonised the responses. As tri¬
cyclic antidepressant drugs block the uptake of monoamines
into nerve terminals in the brain (Ross & Renyi, 1967), it
is possible that uptake blockade was responsible for the
observed potentiation of neuronal responses. Indeed, it
has been reported that, after pretreatment with 6-
hydroxydopamine, desipramine fails to potentiate responses
of Purking'e cells to NA (Hoffer et al, 1971). This obser¬
vation could indicate the importance of monoamine containing
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terminals for the potentiation of neuronal responses.
There are, however, observations in the periphery
which cannot easily be accommodated by the uptake blockade
hypothesis of potentiation. Firstly, there are agonists
which are not taken up into adrenergic terminals, but
responses to which can be potentiated by tricyclic anti¬
depressants. For example, it has been reported that
imipramine potentiates the vasopressor response to isop-
renaline (Schaeppi, 1960) when it is known that isoprenaline
is not taken up into sympathetically innervated tissues
(Iversen, 1967). Responses to 5HT are also potentiated
by imipramine and desipramine (Gyermek & Possemato, 1960;
Sigg et al, 1965) although there is no active uptake
mechanism for 5HT into adrenergic terminals (Iversen, 1967).
Moreover, responses of the nictitating membrane to 5HT, in
contrast to NA, can be potentiated even in the sympatheti¬
cally ^enervated preparation (Gyermek & Possemato, 1960).
Secondly, there are tissues where the tricyclic antidep¬
ressants block the uptake of NA into adrenergic terminals,
but fail to potentiate responses to NA. This has been
reported to occur in the Auerbach's plexus longitudinal
smooth muscle preparation of the guinea pig (Govier,
Sugrue & Shore, 1969). Finally, there are tricyclic
antidepressants which potentiate responses to NA although
they are ineffective as uptake blockers. Thus the pressor
response to NA is potentiated by iprindole (Gluckman &
Baum, 1969) although it is known that iprindole has no
effect on catecholamine uptake into tissues (Gluckman &
Baum, 1969; Lahti & Maickel, 1971).
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Furthermore, it has been reported by Mundo,
Bonaccorsci, Bareggi, Franco, Morselli, Riva and Garattini
(1974) that the potency of tricyclic antidepressant drugs
in blocking catecholamine uptake and potentiating catechol¬
amine effects do not correlate. These authors could find
no correlation between the order of potencies of a range
of tricyclic antidepressants in blocking NA uptake and
potentiating NA responses. They concluded that inhibition
of uptake was not a valid parameter for predicting a
potentiating effect.
There are also observations on single neurones which
cannot be explained by the uptake blockade hypothesis. It
has been shown that sotalol and methysergide have a dual
effect on responses to NA, 5HT and mescaline: small doses
potentiate and higher doses antagonise the responses
(Sevan et al, 1974a; 1974b) and it is known that methy¬
sergide is only a weak inhibitor of 5HT uptake (Born et al,
1972). It has also- been shown that not only responses to
monoamines, but also responses to ACh, can be modified by
tricyclic antidepressant drugs; smaller doses potentiate
and larger doses antagonise the responses (Bevan et al,
1973c; 1975a). As there is no evidence that ACh uptake
occurs (Katz & Chase, 1971) the potentiation of responses
to ACh cannot be explained on the basis of uptake blockade.
Furthermore, cholinesterase inhibition cannot explain
potentiation of neuronal responses" to ACh (Bevan et al,
1975a).
The experiments described in this thesis have
attempted to examine the validity of the uptake blockade
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hypothesis of potentiation, The interaction between tri¬
cyclic antidepressant drugs and monoamine effects was
examined, using the technique of microelectrophoresis, in
three situations where the blockade of monoamine uptake
into nerve terminals was unlikely to contribute to the
effects observed. Thus, it has been shown that desipramine
potentiates the responses of s ingle caudate neurones to
NA, 5HT and DA, although desipramine has been shown not to
block the uptake of these amines in the caudate nucleus
(Ross & Renyi, 1967; 1669). Furthermore, it has been
demonsr::r c-fed that.iprindole can potentiate neuronal res¬
ponses to NA, DA and 5HT although it is known that iprindole
does not block the uptake of monoamines into brain tissue
(Ross et ai, 1971). Finally, the effect of desipramine on
responses of single cortical neurones to mescaline was
examined. An active uptake mechanism for mescaline has
been demonstrated in the cerebral cortex. It has been
shown that desipramine does not block the uptake of mescaline
into synaptosomes. Nevertheless, responses of single cor¬
tical neurones to mescaline are potentiated by desipramine.
There are ample data, then, from both the central and
peripheral nervous systems, which do not confirm the causal
relationship assumed between uptake blockade and poten¬
tiation: tricyclic antidepressant drugs have been shown to
potentiate monoamine effects independent of an uptake
blocking action. Such results, however, cannot deny that
uptake blockade may result in potentiation, but argue that
uptake blockade is not a prerequisite for potentiation.
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The results presented above (Chapter 3) show that
the tricyclic antidepressant drugs desipramine and iprindole
have a dual effect on neuronal responses to monoamines and
ACh. Both antagonism and potentiation of the neuronal
responses to the agonist (NA, 5HT, DA or ACh) could be ob¬
served after a brief application of the antidepressantc
When both antagonism and potentiation occurred after a
single application of the antidepressant, antagonism
invariably preceded the development of potentiation. After
a brief ejecting pulse, the concentration of the antidep¬
ressant rises quickly to a peak and then gradually declines
(Castillo & Katz, 1955). Antagonism of the response is
therefore likely to reflect a higher, and potentiation .a
lower concentration of the antidepressant. Therefore,
the dual effect, of antidepressant drugs on neuronal res¬
ponses to monoamines and ACh appears to be dose-dependent:
smaller doses potentiate and bigger doses antagonise the
responses (see also Bradshaw et al, 1974; Bevan et al,
1975a).
The most plausible interpretation for the anta¬
gonism of neuronal responses by tricyclic antidepressant
drugs is the blockade of postsynaptic receptors. The
anti-noradrenergic, anti-serotoninergic and anticholinergic
effects of tricyclic antidepressant drugs are well docu¬
mented in the periphery (Domenj'oz & Theobald, 1959).
However, as uptake blockade is not a complete explanation
for potentiation, it is possible that not only antagonism
but potentiation of the responses is due to postsynaptic
effects (Bevan et al, 1974a; Bradshaw et al, 1974;
Ill -
Szabadi & Bradshaw, 1974; Bevan et al, 1975a). There
is evidence suggesting that both excitatory and inhibitory
receptors to the monoamines (Szabadi & Bradshaw, 1974) and
ACh (see Bevan et al, 1975a) can coexist on the same
neurone. The presence of the two kinds of receptors is
often apparent in the case of biphasic responses. In the
case of monophasic responses, however, the effect of one
kind of receptor may be completely masked by the effect of
the other (dominant) receptor which determines the direction
(excitation or depression) of the observed response. Thus
potentiation may be due to the selective blockade of the
masked receptors by a small concentration of the antidep¬
ressant whereas antagonism may result from the blockade of
both masked and dominant receptors by a higher concentration
of the drug.
Consider, for example, the case of an excitatoijy
response. It is possible that this monophasic response
reflects the activation of functionally opposite masked
inhibitory and dominant excitatory receptors. The activa¬
tion of the inhibitory receptors would attenuate the effects
of the dominant excitatory receptors. By blocking the
inhibiroiy receptors selectively, the attenuation is removed
and the response therefore potentiated. However, blocking
both receptor populations results in the antagonism of the
response. In this example, the antidepressant would have
a higher affinity for the inhibitory receptors than for the
excitatory receptors so that a low dose results in the
potentiation and a high dose in the antagonism of the
response. Of course, if the antidepressant has a higher
ADDITION TO 1ST PARA. P.112
When an. excitatory response is potentiated, or an
inhibitory response is reversed, the inhibitory receptors
would be selectively blocked and, conversely, when an
inhibitory response is potentiated or an excitatory response
is reversed, the excitatory receptors would be selectively
blocked. Thus, if this hypothesis is correct, desipramine
and iprindole would be more effective in blocking excitatory
receptors on some neurones while on others they would be more
effective against inhibitory receptors. It is difficult to
explain why a drug should have, among the same group of
neurones, such a dual effect on excitatory and inhibitory
receptors and the hypothesis must be regarded as tentative
until further experiments have been carried out.
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affinity for the dominant excitatory receptors, then a low
dose of the antidepressant would block the excitatory recep¬
tors selectively, unmasking the effect of the inhibitory
receptors, Thus the direction of the observed response
would be reversed (see for example Figure 17).
Iprindole differs from imipramine and desipramine in
that it does not block the uptake of monoamines into brain
tissue (Ross et al, 1971). It would appear, therefore, that
the common action of antidepressaint drugs is not their
ability to block monoamine uptake into nervous tissue.
How/ever, all tricyclic antidepressant drugs seem to share
the ability to potentiate and antagonise neuronal responses
to monoamines and ACh (Table 11). In contrast to the
tricyclic antidepressant drugs, the monoamine antagonists
methysergide and sotalol potentiate and antagonise responses
to monoamines without affecting responses to ACh (Sevan et
al, 1974a; 1974b). Similarly, the cholinergic antagonist
atropine potentiates and antagonises responses to ACh with¬
out affecting responses to monoamines (Johnson et al, 1969a).
A common feature of the tricyclic antidepressant drugs may
thus indeed be their ability to block both monoamine and
ACh receptors in the brain.
As tricyclic antidepressant drugs may inter?,ct with
several neurotransmitter substances, it is possible that a
given concentration of an antidepressant could interact
with neurotransmitters differentially. For example, the
therapeutic concentration of desipramine could antagonise
cholinergic transmission whilst potentiating monoamine
transmission. The balance between neuronal systems could
therefore be modified in the presence of the antidepressant.
TABLE11
Imipramine Desipramine Iprindole Sotalol Methysergide Atropine
Effectsoftricyclicantidepressantsandntago istso
responsesofsi glecorticalneuronestpot ntialneurotransmitters Noradrenaiine5-hydroxytryptamineD pamineAcet lcholine P.A(1) P,A(1) P,A P,A(3) P,A(3) 0(4)P,A(1) P,A(1) P.A P,A(3) P,A(3)P,A P,A Potentiation;A=ntagonism;notaffected;
P.-A(2; P,A(2) P,A 0(3) 0(3) P,A(2)
=•notstudied.
(1)Bradshaw,Roberts&Szab di(1974) (2)Bevan,Bradshaw&Szab di(1975a) (3)Sevan,Bradshaw&Szab di(1974b) (4)Johnson,Roberts,S bieszek&Straughan(1969a) (5)Poberts*Straughan(1967) (6)Stone2972)
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